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Abstract
The glycolytic enzyme phosphoglycerate mutase from Saccharomyces
cerevisiae catalyzes the interconversion of 2- and 3-phosphoglycerate via a
Ping-Pong mechanism involving a phosphorylated histidine residue. It also shows a
low level of phosphatase activity which is thought to be a result of the
non-productive transfer of a phospho group to water.
The C-terminal 14 residues are not seen in the electron density map and are
thought to constitute a flexible tail, which has been suggested to be involved in
catalysis by closing over the active site and excluding water. Attempts to construct a
mutant lacking the tail region were unsuccessful, but limited proteolysis of the wild
type enzyme show the importance of the tail in the mutase reaction. The phosphatase
activity is unaffected. Further evidence for the involvement of the tail comes from
studies using a range of inhibitors which have been modelled in the active site. These
provide protection from proteolysis similar to that provided by the substrate
2,3-bisphosphoglycerate. The other substrate, 3-phosphoglycerate, does not provide
this protection.
The two C-terminal residues are both lysines, and it has been suggested that
they are involved in catalysis. Three mutants in which one or both lysines are
replaced by glycine have been characterized (K246G, K245G and K245G/K246G).
The K246G mutant has kinetic properties almost identical to the wild type. When the
lysine 245 residue is replaced, there are some differences in the kinetic parameters of
the resulting mutants which suggest changes in the binding of the substrate and/or
release of the product, but it is unlikely that either lysine is involved in electrostatic
interactions crucial to the catalytic mechanism.
Phosphoglycerate mutase also catalyzes a 2,3-bisphosphoglycerate synthase
activity, although at a much lower level than the mutase activity, and the yeast
enzyme is closely related to the bisphosphoglycerate synthase enzyme present in red
blood cells. This enzyme catalyzes the same three reactions as the yeast mutase, but
the synthase activity is much higher in the erythrocyte enzyme. Comparison of the
amino acid sequences of the two proteins show two significant differences in the
active site region: residues 11 and 60 (S. cerevisiae numbering) are a serine and an
alanine respectively in the yeast mutase, and a glycine and a serine in the erythrocyte
synthase. Characterization of yeast mutase mutants with residues 11 and 60 replaced
by the corresponding synthase residues (S11A and A60S) showed differences in the
catalytic parameters and decreased mutase activity. However, circular dichroism
shows that this could be due to structural differences rather than a change in
functional groups in the active site.
Another active site residue implicated in the catalytic mechanism is glutamate
86. When this residue is replaced with a glutamine, there is a very significant
decrease in mutase activity, and the KM values for each of the substrates are increased
significantly. It has been suggested that this residue is involved in a catalytic triad in
the related enzyme 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase. These
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Glycolysis is a central metabolic pathway, occurring in nearly all organisms,
which provides both energy and metabolic intermediates for other pathways. The
reactions of glycolysis are shown in figure 1.1. The reactions can occur in cells
growing anaerobically as part of a fermentation, or in actively respiring cells, with
the product pyruvate oxidized and entered into the citric acid cycle.
1.2 The phosphoglycerate mutases.
Phosphoglycerate mutase (PGAM) catalyzes the interconversion of 3- and
2-phosphoglycerate in the lower half of the glycolytic pathway. The enzyme was first
discovered over 60 years ago (Meyerhof and Kiessling, 1935), and has subsequently
been found to be almost ubiquitous, found in all organisms so far studied with the
possible exception of some thermophilic archaea (De Rosa et al., 1984, Budgen and
Danson, 1986).
There are two main types of mutase - those which require small quantities of
2,3-bisphosphoglycerate for activity (termed cofactor-dependent mutases) and those
which do not have this requirement (cofactor-independent). The two types show no
significant sequence similarity and are therefore probably heterologous.
Vertebrates possess only cofactor-dependent, and higher plants only cofactor-
independent mutases. In other groups of organisms the situation is less clear-cut. The
mutases from the fungi Saccharomyces cerevisiae and Schizosaccharomyces pombe
are cofactor-dependent (Cameras et al., 1982, Price et al. 1985), whereas those from
Neurospora crassa and Aspergillus nidulans (filamentous fungi) are
cofactor-independent (Huang et al., 1993, Johnson and Price, 1988). Both types can
also be found in bacteria. Mutases from Bacillus spp. have been found to be
cofactor-independent, although they are so far unique in also displaying an absolute
requirement for Mn2+ (Singh and Setlow, 1979, Watanabe and Freese, 1979). It was
thought until recently that all gram-negative bacteria had cofactor-dependent
mutases, but a gene from Pseudomonas syringae has been shown to have






































The reactions of glycolysis, highlighting the phosphoglycerate mutase reaction.
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This complex distribution has been reviewed (Fothergill-Gilmore and Michels, 1993)
and it is likely that both types of gene were present early in evolution, with animals
losing the gene encoding the independent mutase before the radiation of vertebrates,
and plants losing the dependent type gene around the time of the diversion of more
complex forms from the primitive single cells (see section 1.6).
1.3 Cofactor-independent mutases
These mutases tend to be unstable and are consequently difficult to purify.
This has limited the amount of data available. However, mutases from Bacillus spp.
and more recently some higher plants (castor and maize) have been studied in some
detail.
In the absence of added Mn2+, Bacillus does not sporulate, and there is a
build-up of 3-PGA. The block occurs at phosphoglycerate mutase (Singh and Setlow,
1979). The enzyme has been isolated from B. subtilis (Watanabe and Freese, 1979)
and B. megaterium (Singh and Setlow, 1979). Both are monomer molecular weights
of around 61,000 (5. subtilis) and 74,000 (B. megaterium), and show a specific
requirement for Mn2+. The activation is slow and temperature-dependent which
suggests that a conformation change between active and inactive forms is involved.
This interconversion is also pH-dependent (Kuhn et al., 1993). Changes in pH and
Mn2+ concentration occur during sporulation, when significant amounts of
3-phosphoglycerate are accumulated, and these probably regulate the mutase activity
(Magill etal., 1994).
The higher plant mutases are also monomers, with a molecular weight of
around 60,000 (Botha and Dennis, 1986, Huang et al., 1993). The first amino acid
sequence to be reported was from maize, and it contained a cluster of residues that
are highly conserved in the alkaline phosphatase family of enzymes (involved in
metal ion binding). It was therefore suggested that the cofactor-independent enzymes
might be members of this enzyme family (Grana et al. 1992). However, a subsequent
comparison of the amino acid sequences of maize, castor and tobacco showed that
this particular motif is not conserved (Huang et al. 1993). The cofactor-independent
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mutase sequences show a high degree of similarity to each other and may therefore
be homologous.
Higher plant mutases exist as both plastid and cytosolic isoenzymes, both of
which are acid and heat labile, however the cytosolic form is more sensitive to pH.
The catalytic mechanism must differ from that of the cofactor-dependent enzyme,
because 2,3-BPGA has no effect on activity. However, there is evidence that it also
proceeds via a phosphoenzyme intermediate (Breathnach and Knowles, 1977).
Recently, three histidine residues have been shown to be essential for catalytic
activity (Huang and Dennis, 1995). It is therefore possible that although the
cofactor-dependent and -independent enzymes may be heterologous, they are
functionally convergent (catalyzing the same reaction), and may also be
mechanistically convergent both using histidines to mediate the transfer of protons
and phospho groups.
1.4 Cofactor-dependent phosphoglycerate mutases
The glycolytic enzyme, which primarily catalyzes the interconversion of 3-
and 2-PGA, is termed a monophosphoglycerate mutase. There is also a
bisphosphoglycerate mutase (also known as bisphosphoglycerate synthase), found in
mammalian red blood cells. The main function of this enzyme is to maintain levels of
2,3-BPGA, the effector molecule controlling the oxygen affinity of haemoglobin (see
section 1.12).
1.5 Phosphoglycerate mutase isoenzymes
In mammals, there are two genes that encode monophosphoglycerate mutase
(Fundele et al. 1981, Junien et al. 1982). B-type is expressed in brain and most other
tissues except skeletal muscle. M-type is expressed in muscle (cardiac and skeletal).
The gene products, the M and B subunits, have a molecular weight of around 30,000,
and form dimers. The expression of M is developmentally regulated. In early foetal
muscle, only B is expressed giving rise to the BB dimer, which is replaced during
further development by MM through the MB heterodimer. The appearance of the M
gene product correlates with the initiation of spontaneous cell contraction in rat
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satellite cell cultures (Castella-Escola et al. 1990). Birds appear only to have the B
form (Mezquita and Carreras 1981). M and B forms show a high level of sequence
identity, but differ significantly in their basic and acidic amino acid content (Sakoda
et al., 1988). MM, MB and BB isoenzymes have very similar kinetic properties, but
can be distinguished by electrophoretic mobility, thermal lability and sensitivity to
sulphydryl group reagents (Mezquita et al., 1981).
A third gene encodes bisphosphoglycerate mutase (E-type). It shows a high
level of sequence identity with M, B and yeast mutases and is considered another
isoenzyme. The E subunit has been shown to form heterodimers with M and B
subunits in vitro (Pons et al. 1985, Prehu et al. 1988). The gene is expressed in
erythropoeitic cells - foetal liver, spleen and reticulocytes. Trace levels of E mRNA
have also been found in adult liver, which may indicate low level expression in
non-erythroid cells (Joulin et al. 1989). The level of expression of the E-isoenzyme
also changes during development. In developing red cells, there is a low level of
expression of bisphosphoglycerate mutase, and a high level of expression of
glycolytic enzymes. In mature erythrocytes however, there is a high level of BPGAM
expression and low levels of pyruvate kinase (Sasaki et al., 1982). This greatly
increases the flux through the bypass from glycolysis that represents the synthesis
and breakdown of 2,3-BPGA (the Rapoport-Luebering shunt, see section 1.7 and
figure 1.3). In mature red cells this constitutes 15-25% of the overall flux through
glycolysis, and leads to high (mM) levels of 2,3-BPGA, which is the most abundant
phosphorylated metabolite in the red cells of most adult mammals. The levels of
2,3-BPGA rise linearly with rising levels of haemoglobin (foetal haemoglobin has a
higher oxygen efficiency than adult haemoglobin and is much less sensitive to
2,3-BPGA).
1.6 Evolution of the phosphoglycerate mutase isoenzymes
The phosphoglycerate mutase isoenzymes probably evolved from a common
ancestor by two separate gene duplication events, and their evolution can be studied
by looking at their distribution. As described in section 1.4, the E isoenzyme
(bisphosphoglycerate mutase) is responsible for maintaining the levels of
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2,3-bisphosphoglycerate, an effector molecule for haemoglobin in mammals and
amphibia. Inositol pentaphosphate and ATP are important effectors in birds, and the
latter is also important in fish, amphibia and reptiles. Therefore in considering the
position of the divergence of the E-isoenzyme, the distribution of haemoglobin
effector molecules is relevant.
Fish and higher vertebrates have both M and B isoenzymes, but birds only
have the B-type. Evidence for the B-type being the ancestral form comes from its
wider distribution and from the presence in the human and mouse genomes of a large
number of pseudogenes that are related to the B gene and not M (Sakoda et al.,
1988). As B is found in both mammals and birds, the divergence of the M and B
types probably occurred before the radiation of the mammalian line (around 400
million years ago). Reptiles have both genes, so the M-type was probably lost from
birds after divergence from reptiles (145 million years ago).
Looking at effector function distribution, the gene duplication giving rise to
the E-type gene can be placed after the divergence of mammals and fish (400 million
years ago) but before the divergence of mammals and amphibia (300 million years
ago). The E isoenzyme is present in amphibia and higher vertebrates. This scheme is
shown in figure 1.2 A (from Fothergill-Gilmore and Michels, 1993).
An alternative scheme is suggested by a comparison of the isoenzyme
sequences. The M- and B-types are more similar to each other than either is to the
E-type. If a constant rate of evolution is assumed, this would imply that the E
isoenzyme diverged from a B/M ancestor and was subsequently lost from the fish
and reptile/bird lines. The B and M isoenzymes then diverged before mammalian
radiation (Sakoda et al., 1988). This scheme is shown in figure I.2.B.
Until more sequences are available, it is not possible to determine absolutely
which scheme is correct, but Fothergill-Gilmore and Michels favour the first, as it
requires the loss of an isoenzyme in only one line. It is possible that the rate of
evolution of the E-gene is not constant, and that it underwent rapid change after gene

















Possible schemes showing the evolution of the phosphoglycerate mutase isoenzymes.
8
1.7 The Reactions of Phosphoglycerate mutases
The reactions catalyzed by cofactor-dependent phosphoglycerate mutases are
shown in figure 1.3. The monophosphoglycerate mutase reaction was first described
by Meyerhof and Kiessling in 1935, and the bisphosphoglycerate mutase reaction by
Rapoport and Luebering in 1950. The bisphosphoglycerate mutase activity is usually
termed the synthase activity to avoid confusion with the glycolytic reaction.
It was originally supposed that the three activities were catalyzed by three
different enzymes, but the attempts to purify both the monophosphoglycerate mutase
from various sources and the bisphosphoglycerate synthase from erythrocytes
resulted in the co-purification of the other activities (Rose, 1968, Sasaki et al., 1971,
Laforet et al., 1974, Rosa et al., 1975). Shortly after, it was shown that the three
activities were indeed catalyzed by a single polypeptide, and at a common active site
(Rosa et al., 1973, Sasaki et al., 1975, Ikura et al. 1976). The rate at which the three
reactions are catalyzed differs significantly in mono- and bisphosphoglycerate
mutases. The monophosphoglycerate mutases catalyze the mutase reaction at a rate
some four orders of magnitude higher than the synthase and mutase reactions.
Bisphosphoglycerate mutase (the E isoenzyme) from red blood cells catalyzes the
synthase activity at a higher rate than either of the other two activities (Rose, 1980).
As monophosphoglycerate mutase is also present in erythrocytes, it is
unlikely that the E-isoenzyme is important in glycolysis. The function of
bisphosphoglycerate mutase is to maintain the high concentration of 2,3-BPGA
found in erythrocytes, where it is an important regulator of haemoglobin oxygen
affinity. The synthase and phosphatase activities of this enzyme constitute a bypass
of the phosphoglycerate kinase step of glycolysis (known as the Rapoport-Luebering
shunt) controlling the synthesis and breakdown of 2,3-BPGA.
The phosphatase activity of both mono- and bisphosphoglycerate mutases is
very low, but is increased by anions, in particular the two carbon substrate analogue
2-phosphoglycollate (Rose and Liebowitz, 1970, Sasaki et al., 1971, Rose and Dube,
1976). In erythrocytes, the rate of the phosphatase reaction is not thought to be




The reactions catalyzed by cofactor-dependent phosphoglycerate mutases.
A. The glycolytic mutase reaction.
B. The bisphosphoglycerate mutase reaction (known as the synthase reaction).
C. The bisphosphoglycerate synthase reaction.
The synthesis and breakdown of 2,3-BPGA constitute a bypass of glycolysis known
as the Rapoport-Luebering shunt.
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in saturation - the KM for the substrate is in the micromolar range and the substrate is
present in the millimolar range. The rate may therefore be at least partially dependent
on the levels of activators present. Rose and Salon (1979) showed that
2-phosphoglycollate is present in normal red blood cells at levels sufficient to
enhance the phosphatase activity of bisphosphoglycerate synthase. The
cofactor-independent mutases only exhibit the glycolytic mutase reaction.
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Table showing the catalytic constants for the reactions catalyzed by the
phosphoglycerate mutases. Abbreviations: MPGAM-ind, cofactor-independent
phosphoglycerate mutase from wheatgerm (Leadley et al., 1977); MPGAM-dep,
cofactor-dependent phosphoglycerate mutase from chicken muscle (Rose, 1980);
BPGAM, bisphosphoglycerate mutase from horse red cells (Rose, 1980). The kcat for
the phosphatase reaction is for the reaction activated by 2-phosphoglycollate.
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1.8 Structure of the phosphoglycerate mutases.
1.8.1 Primary Structures.
Complete amino acid sequences are available for a number of
cofactor-dependent phosphoglycerate mutases: S. cerevisiae (Fothergill and Harkins,
1982, White and Fothergill-Gilmore, 1988), S. pombe (Nairn et al., 1994),
Streptomyces coelicolor (White et al., 1992), Zymomonas mobilis (Yomano et al.,
1993), the rat M and B isoenzymes (Castella-Escola et al., 1989, Urena et al., 1992),
human M and B isoenzymes (Shankse et al., 1987, Sakoda et al., 1988), and the E
isoenzyme from human, rabbit and mouse erythrocytes (Haggarty et al., 1983, Joulin
et al., 1986, Yanagawa et al., 1986, LeBoulch et al., 1988). The sequences are shown
aligned in figure 1.4, and sequence identities are given in table 1.2. The high level of
identity shows that the phosphoglycerate mutases have the slow rate of evolution
typical of glycolytic enzymes.
1.8.2 Tertiary structure
The crystal structure of only one phosphoglycerate mutase has been
determined - that from S. cerevisiae. Until very recently, the only structure available
was that determined by Winn et al. (1981). There are a number of problems with this
structure. It is of relatively poor resolution (2.8 A), and is based on an amino acid
sequence that has since been shown to have a number of errors (Fothergill and
Flarkins, 1982, White and Fothergill-Gilmore, 1988). However, this structure has
formed the basis of protein engineering work on the yeast mutase, in particular the
work contained in this thesis, and therefore it should be described in some detail.
The 2.8A structure shows the enzyme as a homotetramer, arranged with
almost exact 222 symmetry. The tetramer is shown in figure 1.5. Each subunit
consists of a polypeptide chain folded into a single domain, consisting of a central
core of p-strands surrounded by a-helices. The arrangement is similar to the
nucleotide-binding domain of dehydrogenases (Ohlsson et al., 1974). However, no
nucleotide binding requirement has been demonstrated for PGAM, although these
molecules can bind to PGAM. The active site was located by soaking crystals of
12
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Alignment of the amino acid sequences of cofactor-dependent phosphoglycerate
mutases.
Abbreviations: Abbreviations: S. cerev, S. cerevisiae PGAM (White and
Fothergill-Gilmore, 1988); S.pombe, S. pombe PGAM (Nairn et al. 1994); S.coel,
Streptomyces coelicolor PGAM (White et al., 1992); Z.mob, Zymomonas mobilis
PGAM (Yomano et al., 1993); Hum-M, human M-type PGAM (Shankse et al., 1987);
Rat-M, rat M-type PGAM (Castella-Escola et al., 1989); Hum-B, human B-type
(Sakoda et al., 1988); rat-B, rat B-type (Urena et al. 1992); Hum-E, human E-type
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Figure 1.5
The S. cerevisiae PGAM tetramer (2.8A structure, Campbell et al., 1974, Winn et al
1982).
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PGAM in 3-PGA (Winn et al. 1981). The enzyme used in the study was not
phosphorylated, and therefore was inactive as a mutase. However, 3-PGA acts as a
competitive inhibitor with respect to 2,3-BPGA at high concentrations and confers
protection against reagents known to modify the active site, so it is reasonable to
assume that the monophosphoglycerate substrate can bind to the active site of the
unphosphorylated enzyme. The results obtained by soaking the crystals in 3-PGA
show that the active site lies at the bottom of a hollow formed by the residues of one
subunit only. The four sites are well separated in the tetramer (figure 1.5) and appear
to be freely accessible to the solvent.
A single subunit showing active site residues is shown in figure 1.6. The
crystals were grown in ammonium sulphate, and in the crystal structure, sulphate
ions occupy the positions in the active site presumed to be occupied in the ligated
enzyme by the phospho groups of 2,3-BPGA. A second sulphate is thought to occupy
the position of the non-transferred phospho group of the 2,3-bisphosphoglycerate
substrate/cofactor. Figure 1.7 shows the active site with bound sulphate ions.
Assuming the transferable phospho group binds in these positions, the oxygen atoms
could form hydrogen bonds with the hydroxyl groups of Serll and Thr20. The
hydroxyl on C2 of the monophosphoglycerate substrate could make a hydrogen bond
with a main chain carbonyl oxygen. The phospho group on C2 of 2,3-BPGA in a
similar position to sulphate 2 could interact with the positive charge associated with
the dipole at the N-terminus of helix 7. The CI carboxyl points towards the back of
the active site, near to Arg59. As described in section 1.9, Pizer and Ballou (1959)
showed a substrate requirement for this negatively charged group on CI, and this
charge-charge interaction could help position the substrate for phospho transfer.
Two histidines are located in the active site and are arranged in a distinctive
"clapping hands" formation, parallel and about 4A apart. His8 is close to the 3-PGA
phospho group, and Hisl 81 is close to the hydroxyl on C2. The active site pocket is
lined by several positively charged side chains, particularly of arginine, as would be
expected where the substrates are negatively charged.
A new, higher resolution (2.3 A) structure has recently been determined
(Rigden et al., 1997). This shows some important differences to the earlier structure.
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Figure 1.6
A single subunit of S. cerevisiae PGAM, showing active site residues mentioned in
the text (2.8A structure, Campbell et al., 1974). The substrate is shown in the active
site, which was located by soaking crystals in a solution of 3-PGA (Winn et al.,
1982). No electron density was observed after residue 232. Residues 233-246 are
represented by symbols. Lysines are shown as stars, small uncharged residues as
open circles and polar residues as closed circles.
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Figure 1.7
The active site of S. cerevisiae PGAM, showing key residues and the two bound




Ribbon diagram of a single subunit of S. cerevisiae PGAM, with alpha helices
labelled 1-12 and beta strands A-K (2.3A structure, Rigden et al., 1997).
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Each subunit is made up of two domains; in addition to the large domain with the
nucleotide binding fold which was identified in the previous structure, there is
another smaller domain in a region which was previously considered to have little
secondary structure. It is made up of short P-strands and a-helices. Figure 1.8 shows
a single subunit showing the two domains. The two active site histidines are found at
the ends of strands A and G. The catalytic site is situated at the bottom of a deep
cleft, 7A deep and with a minimum diameter of 7A (the cleft is narrower and deeper
than in the 2.8A structure). This diameter could be increased by movements of the
side chains of the many lysine and arginine residues in the cleft. The two histidines
(His8 and Hisl81) are shown not to be in the "clapping hands" conformation, but in
an orientation closer to that seen in two other histidine phosphatase enzymes, rat
prostatic acid phosphatase (RPAP) and fructose-2,6-bisphosphatase (see Section
1.13). They are very close together, 3.2A compared with 4.7A in RPAP and 4.2A in
fructose-2,6-bisphosphatase, but this may be because the mutase was crystallized
with no salt or other ligand in the active site, unlike the other enzymes.
Another key difference between the two structures is the orientation of Glul5.
In the 2.8A structure this was shown to point into the active site, and it was suggested
that the carboxyl side chain may act as a proton withdrawing group from the
hydroxyl on C2 of the substrate. The new structure shows that Glul5 in fact faces
away from the active site and therefore any role in catalysis is unlikely.
The positions of key active site residues is shown in figure 1.9. Arg59 is still
situated near the two histidines, and its position is compatible with the role
previously suggested - interacting with the carboxyl group of the substrate. Arg7
could also be involved in ligand binding. The hydroxyl group of Ser55 is likely to
contribute to the orientation of the Hisl 81 side chain by hydrogen bonding to atom
NE2. Hisl81 and Arg59 are within hydrogen bonding distance of His8, which
suggests that this residue is unprotonated (see figure 1.10). This is required for the
suggested mechanism (section 1.10).
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Figure 1.9
Stereo diagram of the active site of S. cerevisiae PGAM, showing the catalytic




Stereo diagram of the H-bonding network around His8. H-bonds are represented by
dotted lines and their lengths in A are given.
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1.8.3 Quaternary Structure
The cofactor-dependent phosphoglycerate mutases are unusual in that the
most active form of the enzyme can be found in a variety of oligomeric structures
depending on the organism from which it is isolated. For example, the mutases from
Saccharomyces cerevisiae, Penicillium janthinellum and Fasciola hepatica are
tetramers (Edelhoch et al., 1957, Willets, 1980, Shulman and Valentino 1982), the
vertebrate and bacterial (Zymomonas mobilis and Escherichia coli) enzymes are
dimers (Cowgill and Pizer, 1956, Pawluk et al. 1986, D'Alessio and Josse, 1971), and
the enzymes from Schizosaccharomyces pombe and Pseudomonas AMI are
monomers (Price et al. 1985, Hill and Attwood, 1976). PGAM is the only glycolytic
enzyme that displays this range of fully active oligomeric forms. Hexokinase,
phosphofructokinase and pyruvate kinase are found in different forms, but these
display different activities and are probably the result of a control mechanism.
PGAM shows no cooperativity between subunits.
The 2.8A structure of the S. cerevisiae tetramer (figure 1.5) has two main sets
of intersubunit contacts. The most extensive is termed CR (contact region) 1/2 and
involves residues in p strand I, helix 2 and in the connecting loop, i.e. the 25 residues
from Leu57 to Ser81. The side chains of the residues of the connecting loop (Leu74
to Val78) are thought to fill a hydrophobic pocket formed by the adjacent subunit,
stabilizing the CR1/2 intersubunit contacts in the tetramer. These are essentially
conserved in all the tetrameric and dimeric PGAMs (see figure 1.4) but in the
S.pombe enzyme there are some radical substitutions, Trp75 to Asn, and Pro77 to
Glu (S.cerevisiae numbering). These substitutions would be likely to weaken the
interactions across the interface (Nairn et al. 1995).
The second set of contacts is termed CR5. In the S. cerevisiae structure, this
set involves interactions between the side chains of residues in the loop preceding
helix 5 (Tyrl39 to Vall44), which fit between side chains in helix 6 and the loop
region between strands 5 and 6 of the symmetry-related subunit. In the S.pombe
enzyme, there is a deletion of residues 122-146, consistent with its monomeric




The S. cerevisiae PGAM tetramer (2.3A structure, Rigden et ai, 1997).The subunits
are labelled A-D. The ribbons represent the secondary structure involved in subunit
contacts.
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enzymes (figure 1.4) and this could explain the weakening of the CR5 contacts,
giving rise to the dimers.
However, the new structure (Rigden et al. 1997) shows that, rather than one
interface being more extensive than the other, the interfaces in fact bury similar
amounts of solvent-accessible area and there are similar numbers of atomic contacts
at each. The tetramer is shown in figure 1.11. At the A-B interface, most of the
contacts involve helix 3 and strand D. Glul35 and Argl36 from helix 6 also form
contacts. At the A-C interface, contacts are formed by a number of different regions
of the protein. Among the larger contributors are Arg83, residues 163-164 from the
end of helix 8 and residues 138-144. This last region is included in the deletion seen
in the S. pombe mutase. Another residue at this interface is Lysl68, which is a
proline in the dimeric mutases. Site-directed mutagenesis of the lysine to a proline
destabilizes the tetramer (White et al., 1993b), therefore it is probable that the A-C
interface is only present in the tetrameric forms. The S. pombe enzyme has a number
of differences at both interfaces, explaining its monomeric form.
1.8.4 The C-terminal tail.
In the 2.8A structure, the last 14 amino acids are not defined, as they were not
seen in the electron density map, and were therefore thought to constitute a flexible
tail region. The side chains of these residues tend to be small and uncharged, which
would permit this flexibility.
-233a aagaaavanqgk k246
In the new structure, the tail adopts a helical conformation from residue 230
to 234. This short helix (helix 12) can be seen in figure 1.8. The helix makes no
contacts with the rest of the enzyme, which supports the idea that this tail region is
flexible. No structure could be defined after residue 236.
Early attempts to purify the enzyme from yeast gave a mixture of enzyme
forms with differing electrophoretic mobilities. The component with the lowest
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electrophoretic mobility had the highest specific activity and vice versa. The
endogenous protease was partially purified and shown to cause the loss of nine or ten
residues per subunit of PGAM (Sasaki et al., 1966). Comparison of the amino acid
composition of the native and modified enzyme showed that they were similar, but
that the proteolyzed protein contained less alanine, lysine, glycine, valine, aspartic
acid and glutamic acid. The difference between the two corresponded closely to the
number of residues liberated during modification. Alanine, glycine, lysine and valine
are all found at the C-terminus of the protein (the tail region). Removal of these
residues did not alter the optical rotary dispersion pattern of the enzyme, and
although the mutase activity was severely affected, the 2,3-BPGA phosphatase
activity was unchanged. These results indicate that the residues of the C-terminal tail
are important for mutase activity. Further evidence for the importance of this region
comes from site-directed mutagenesis studies on human bisphosphoglycerate mutase
(Garel et al. 1989). These showed that the deletion of a minimum of seven residues at
the C-terminus removed all activity from the enzyme (synthase, mutase and
phosphatase). Deletion of the two C-terminal lysines alone removed 38% of the
synthase activity.
In figure 1.8, it can be seen that the tail could adopt a position over the
entrance to the active site. An interesting feature of the tail is the pair of lysine
residues at the C-terminus, at least one of which is conserved in all the PGAM
sequences so far determined, with the exception of the S.pombe and Z.mobilis
enzymes which lack the region corresponding to the tail (see figure 1.4).
Fothergill-Gilmore and Watson (1989) have suggested three possible roles for
the tail. Firstly, that it physically excludes water from the active site, preventing the
transfer of a phospho group to water instead of to the monophosphoglycerate
substrate. Secondly, that it provides a third phospho ligand for the substrates,
intermediate and transition state (see section 1.8.2). Thirdly, that it helps to retain the
bisphosphoglycerate cofactor-intermediate in the active site during the reaction




The different substrates in the reactions catalyzed by the cofactor-dependent
phosphoglycerate mutases have significantly different KM values. The actual values
of course vary between species, but the overall relationship between them is fairly
constant. Representative values are given in table 1.3.
Km (pM)






phosphatase 2,3-BPGA 0.05 2.5
Table 1.3
The Km values of substrates involved in the reactions catalyzed by
cofactor-dependent phosphoglycerate mutases, taken from Rose, 1980.
Abbreviations: MPGAM, monophosphoglycerate mutase from chicken muscle;
BPGAM, bisphosphoglycerate mutase from horse red cells.
These values are significantly influenced by ionic strength. In the presence of
400mM KC1, the KM values are increased 10-fold (Grisolia and Cleland, 1968).
Modelling studies using the 2.8A structure (see section 1.8.2) show that the
differences could be explained by the extra phospho group of 2,3-BPGA. The
monophosphoglycerates would form the same number and type of specific
interactions. The lower KM for 2-PGA may be due to better hydrophobic contacts
(Fothergill-Gilmore and Watson, 1989). The second phospho group of 2,3-BPGA
would allow additional charge interactions to be formed in active site, which has a
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high overall positive charge. The increased KM2'3"BPGA for bisphosphoglycerate mutase
is probably due to the lack of a specific phospho ligand, Serl 1 (see section 1.13).
1.9.2 Substrate specificity
Pizer and Ballou (1959) tested the ability of a wide range of substrate
analogues to act as phospho donors and/or acceptors in the mutase reaction. Their
experiments defined a number of structural requirements needed for compounds to
participate.
Firstly, carbon 1 (CI) must carry a negative charge. A sulphonic acid group
can substitute for the carboxyl group, but not an aldehyde or a methyl ester. Carbon 2
(C2) is asymmetric. In the natural substrate, the hydroxyl group is in the
D-configuration. The L-isomer can accept a phospho group, but at a considerably
reduced rate. When the hydrogen on C2 is replaced with a methyl group, there is no
phospho transfer, probably due to steric hindrance by the larger group. Carbon 3 (C3)
can carry a methyl group in place of a hydrogen, but only when the hydroxyl groups
on C2 and C3 are in the D-erythro configuration. When the hydroxyl group is
replaced with an amino group, as in serine phosphate, there is no phospho transfer.
In summary, acceptor molecules are required to have three groups: a carboxyl
or charged equivalent, a phospho group and a hydroxyl. Donor specificity was tested
by assaying ability to activate the enzyme. Only diphosphates of phosphoglycerate
and D-erythro-hydroxybutyric acid were active. ATP, ADP, CTP, UTP and creatine
phosphate all showed no donor activity.
1.10 Enzyme Mechanism
Sutherland et al. (1949) used l2P radiolabeled 3-PGA in the mutase reaction
and showed that the label becomes distributed amongst the three ligands, 3-PGA,
2-PGA and 2,3-BPGA. This suggests that the 2,3-BPGA must bind to the active site
and be formed by the phosphorylation of the monophosphoglycerate. Ionic strength
affects the pattern of labelling (Cascales and Grisolia, 1966). In low salt
concentrations, 2-PGA is preferentially labelled, whereas at higher concentrations
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(-0.5M), 2,3-BPGA is favoured. Higher salt concentrations presumably promote the
dissociation of the BPGA intermediate.
Early attempts to determine the mechanism of the enzyme gave conflicting
results. Grisolia and Cleland (1968) suggested a ping-pong mechanism with a
phosphoenzyme intermediate, but Chiba et al. (1970) proposed a sequential
mechanism, with the direct transfer of a phospho group from 2,3-BPGA to a
monophosphoglycerate. Britton and his co-workers developed an induced transport
test based on flux kinetics to confirm that the mutase reaction proceeded via an
intermolecular ping-pong mechanism involving a phosphoenzyme (Britton et al.,
1972, Britton and Clarke, 1972). The reaction kinetics suggest that there is only one
phosphorylation site, as the rate of isomerization of phosphoenzyme intermediates
would be not less than 4x106 sec"1, which is unrealistically rapid (Britton and Clarke,
1982). Therefore the monophosphoglycerates must bind so either C2 or C3 can be
phosphorylated, and 2,3-BPGA so that either phospho group can be transferred, i.e.
the substrate can bind in two different orientations, or can bind in a position where
C2 and C3 are both close to the phosphorylation site.
In the enzyme phosphoglucomutase, which also has a phosphoenzyme
intermediate involved in its mechanism, the residue which is phosphorlyated is the
serine. The pH profile for isotope exchange with PGAM suggests the involvement of
a histidine site in the mechanism (Cascales and Grisolia, 1966). Rose (1970) showed
that the phosphoenzyme bond is acid labile and alkaline stable, which strongly
suggests a phosphohistidine. Subsequently the sequences of active site peptides
containing a phosphohistidine have been identified, and show that His8 (yeast
numbering) is the phosphorylation site (Han and Rose, 1979, Haggarty and
Fothergill, 1980, Hass et al., 1980, Fothergill and Harkins, 1982).
A mode of action for the cofactor-dependent phosphoglycerate mutases has
been suggested by Fothergill-Gilmore and Watson (1989). Firstly, a 2,3-BPGA
molecule binds in the active site of the unligated enzyme in one of two orientations.
One position is with the phospho group on C2 near to His8, also near enough to form
hydrogen bonds with Serl 1 and Thr20. They also suggest that a third phospho ligand
is provided by the C-terminal lysines (Section 1.8.4). The phospho group on C3
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interacts with the positive charge on the dipole at the N-terminus of helix 7. The
other position has these two phospho groups reversed. The carboxyl group is in a
position to form a salt bridge with Arg59. Phospho transfer from BPGA to His-8 then
occurs, and a proton is provided by Hisl81. This role for the second active site
histidine was suggested by Rose (1980) and is supported by mutagenesis studies in
which this residue is replaced by an alanine, with an associated decrease of catalytic
efficiency (White and Fothergill-Gilmore, 1992). The resulting
monophosphoglyerate is then released leaving the phosphoenzyme.
Either a 3-PGA molecule (in glycolysis) or 2-PGA (gluconeogenesis) binds to the
active site, and the phospho group on His8 is transferred to the carbon atom carrying
the hydroxyl group, forming a 2,3-BPGA intermediate. This molecule must then
reorientate itself in the active site, so the phospho group that has not just been
transferred is now adjacent to His8. Another phospho transfer occurs, and the
monophosphoglyerate product is released leaving the phosphoenzyme ready for
another round of catalysis.
The half life of the phosphoenzyme has been measured at 1-2 minutes
(Britton et al. 1972a), and so the observed low level of phosphatase activity could be
due to the hydrolysis of the phosphoenzyme.
1.11 Inhibitors
1.11.1 Substrates and substrate analogues
In a multifunctional enzyme which catalyzes more than one reaction, the
substrate of one of the reactions is likely to act as a competitive inhibitor of another.
As expected, 3-PGA, 2-PGA, 2,3-BPGA and 1,3-BPGA all act as competitive
inhibitors at certain concentrations (Rose, 1980). Another important group of
inhibitors are substrate analogues. The phosphonomethyl analogues of 3-PGA and
2,3-BPGA act as competitive inhibitors, with K, values of 1.3mM and 0.8mM
respectively. These molecules have the bridge oxygen replaced with a methylene
group, and cannot transfer a phospho group, but are thought to bind to the active site
in the same orientation as the substrates.
30
1.11.2 Anions
The natural substrates are all negatively charged, and the active site has a
large overall positive electrostatic potential (Warwicker, 1986, Rigden et ai, 1997),
and anions have been found to act as potent inhibitors. As has already been
described, salts have a significant effect on the enzyme activities (Cascales and
Grisolia, 1966). These include sulphate, phosphate and chloride. Among the most
effective inhibitors are a number of polycarboxylates and polyphosphates, which
have K; values in the micromolar range. These are competitive with 2,3-BPGA and
not with the monophosphoglycerate substrate analogue 2-phosphoglycollate, and
therefore presumably bind to the non-phosphorylated enzyme (Rose, 1980). This
class of inhibitor will be discussed in more detail in chapter five.
1.11.3 Vanadate
The cofactor-dependent, but not the cofactor-independent phosphoglycerate
mutases are inhibited by micromolar concentrations of vanadate (Carreras and
Bartrons, 1980). It is thought to act by destabilizing the phosphoenzyme, as the
hydrolysis of the phosphoenzyme is increased, as is the phosphatase activity
(Carreras et al., 1982). The synthase activity, like the mutase activity, is decreased.
Stankiewicz et al. (1987) showed that divanadate binds with a considerably higher
affinity than the mono form, and it has been suggested that the dimer binds at the
catalytic site of the phosphoenzyme as a substrate analogue, activating hydrolysis.
The same workers have shown that 2-or 3-PGA potentiates the inhibition of PGAM
by vanadate, and therefore have suggested that the inhibitor is a complex of
monophosphoglycerate and vandate (2-vanadio-3-phosphoglycerate), acting as a
transition state analogue for the transfer of the phospho group between the enzyme
and monophosphoglycerate (Liu et al., 1992). This complex is a more potent
inhibitor than the divanadate, and when incubated with the enzyme-vanadate
complex, results in the release of vanadate.
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1.12 The mutase/synthase relationship
2,3-BPGA is present only in trace amounts in most mammalian cell types
(Grisolia and Joyce, 1959, Chiba et al., 1974), but at a considerably higher
concentration in red blood cells (Harkness et al. 1969, Brewer and Eaton, 1971).
Here the molecule acts as the most important regulator of haemoglobin oxygen
affinity, binding preferentially to deoxyhaemoglobin and facilitating the unloading of
oxygen in the tissues (Benesch and Benesch, 1968). The synthesis of 2,3-BPGA in
red blood cells is catalyzed by the enzyme bisphosphoglycerate synthase (or
bisphosphoglycerate mutase), EC 5.4.2.4 (Rapoport and Luebering, 1950). Like
monophosphoglycerate mutase from yeast, this enzyme is trifunctional, also
catalyzing monophosphoglycerate mutase and bisphosphoglycerate phosphatase
reactions. These three reactions have been shown to be catalyzed at a common active
site (Ikura et al., 1976). The nucleotide and amino acid sequences of human red cell
bisphosphoglycerate mutase have been determined (Joulin et al., 1986, Haggarty et
al., 1983), and show that this enzyme shares about 50% sequence identity with yeast
PGAM.
Bisphosphoglycerate mutase catalyzes all three reactions at significant rates.
The ratio of activities for horse red cell bisphosphoglycerate mutase and chicken
muscle monophosphoglycerate mutase are shown below (values taken from Rose,
1980).
BPGAM MPGAM
kcal (ratio) K,t (ratio)
mutase 1.7(1) 1,333 (1)
synthase 12.5 (7.4) 0.4 (3x10"4)
phosphatase 2.6 (1.5) 2.78 (2x10"3)
The essential difference between the two enzymes is that the
monophosphoglycerate mutase releases monophosphoglycerate and regenerates the
phospho enzyme, and the bisphosphoglycerate mutase liberates bisphosphoglycerate
and regenerates the free enzyme. The relative rates of phosphorylation differ, as does
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the preferred phospho donor. The rates have been studied using a continuous flow
and quench system (Rose and Dube, 1976). The preferred reaction of
monophosphoglycerate mutases correlates with the rates of phosphorylation by the
alternative donors. With 2,3-BPGA, the donor in the mutase and phosphatase
reactions, the phosphorlyation rate is rapid (greater than 100 s"1), whereas for
1,3-BPGA, the donor in the synthase reaction, the rate is much slower at 1.57 s"1.
With the bisphosphoglycerate mutase, the rate is more rapid with 1,3-BPGA (13.5
s"1) than with 2,3-BPGA (2.3 s"1). The rates for each donor are more similar with
bisphosphoglycerate mutase than the monophosphoglycerate mutases, which could
explain why the levels of activities for this enzyme are closer. Phospho transfer to the
acceptor molecule (the second substrate) is very fast (>100 s"1) with both enzymes,
but the release of the enzyme-bound phospho group to water in the
2-phosphoglycollate-enhanced phosphatase activity is faster in the
monophosphoglycerate mutase than the bisphosphoglycerate mutase (3.6 s"1 and 16
s"1 respectively). There must therefore be differences between the active sites of these
enzymes which are responsible for the differences in the rate of phospho transfer.
Human bisphoshoglycerate synthase has been crystallized (Cherfils et al.,
1991), but there is as yet no published structure. However, the residues of the active
site can be deduced by comparison with the sequence of the yeast enzyme. There is
considerable identity between the two active sites, and many of the residues thought
to be involved in the enzyme mechanism are conserved. These include two
histidines, His 10 and His 187 (which correspond to His8 and Hisl 81 in the S.
cerevisiae enzyme). His 10 has been shown to be phosphorylated during the catalytic
process (Han and Rose, 1979), and the replacement of this residue completely
abolishes all three enzyme activities (Garel et al., 1993). The Hisl87 residue is also
implicated in the catalytic mechanism by site-directed mutagenesis studies. It has
been suggested that the corresponding residue in the S. cerevisiae enzyme (Hisl81)
donates a proton during formation of the phosphoenzyme and accepts a proton when
the phospho group is transferred to the substrates in the mutase reaction
(Fothergill-Gilmore and Watson, 1989, White and Fothergill-Gilmore, 1992).
However, the formation of the phosphoenzyme in the first step of the synthase
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reaction involves the transfer of an acyl phospho group and therefore does not require
the transfer of a proton. Garel et al. (1993) found that replacing Hisl87 of
recombinant human bisphosphoglycerate mutase with aspartate or tyrosine
completely removed all three activities, while another mutant, H187N, showed
partial preservation of all three. Asparagine is not a proton donor, and so could not
perform this role in the mutase and phosphatase reactions. However, all three
activities were reduced equally in this mutant - there was no greater effect on the
mutase and phosphatase activities as would be expected.
Another conserved residue, Arg89 (Arg87 in S. cerevisiae numbering), has
been implicated in the reaction mechanism by analysis of the primary structure of
bisphosphoglycerate mutase from a patient suffering from decreased 2,3-BPGA
levels. This showed that Arg89 was replaced with a cysteine (Rosa et al., 1989).
Subsequent site-directed mutagenesis studies have shown that replacement of this
positively charged residue with a neutral amino acid leads to an absence of synthase
activity, a decrease in mutase activity and a decrease in the stimulation of the
phosphatase activity by 2-phosphoglycollate. However, the unstimulated phosphatase
activity was conserved or even increased (Garel et al., 1993). Replacement of Arg89
with lysine on the other hand preserves some of the properties of the wild type
enzyme. Synthase and phosphatase activities are maintained, and mutase and
2-phosphoglycollate stimulation are only moderately decreased.
As only the unstimulated phosphatase activity is unaffected when this
positive charge is removed, it would suggest that the binding of
monophosphoglycerates only is affected by the substitution. This is the only activity
where the binding of a monophosphoglycerate is not involved. This gives weight to
the theory that monophosphoglycerates and 2-phosphoglycollate bind at a site
distinct from the bisphosphoglycerate binding site, although these would be likely to
overlap at a single phosphorylation site at His8 of S. cerevisiae
monophosphoglycerate mutase, and HislO of human bisphosphoglycerate mutase
(Rose, 1980, Garel et al., 1993, Ravel et al., 1996).
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The two histidines and the arginine are conserved in mono- and
bisphosphoglycerate mutase. We would expect unconserved residues to be
responsible for the specific functioning of the enzyme as predominantly a mutase or a
synthase.
As described above, studies on the bisphoshoglycerate mutase from human
erythrocytes have suggested the mono- and bisphosphoglycerate substrates bind at
separate sites in the catalytic cleft. The postulated binding site for
monophosphoglycerates involves (using S. cerevisiae numbering) residue 11 (Ser in
monophosphoglycerate mutase and Gly in bisphosphoglycerate mutase), Glul5 and
Lys245. The suggested binding site of bisphosphoglycerates involves residue 21 (Gly
in monophosphoglycerate mutases and Ser in bisphosphoglycerate mutases), and
Arg87 (Ravel et al., 1996). These sites would therefore differ between the mono- and
bisphosphoglycerate mutases. The former would have an extra phospho ligand for
monophosphoglycerates (Ser 11), and the latter would have an extra ligand for the
binding of bisphosphoglycerates. This idea is partially supported by the new S.
cerevisiae PGAM structure (Rigden et al., 1997) which shows that Gly21 and Arg87
are close together, as are Serll and Glul5. However, Glul5 is not solvent-exposed
within the catalytic site cleft but on a different face of the protein, and therefore its
role in substrate binding, at least in the S. cerevisiae enzyme, must be in question.
This structure also suggests that there may be a significant difference between
the two catalytic sites in a least one area. The S. cerevisiae structure shows that
Gly21 is hydrogen bonded by Arg59. This glycine residue has unusual torsion angles
and it is unlikely that the corresponding serine residue in bisphosphoglycerate
mutases adopts the same backbone conformation.
1.13 The histidine phosphatase family of enzymes
The cofactor-dependent phosphoglycerate mutases show significant sequence
similarity with some other enzymes that catalyze different reactions. Rat prostatic
acid phosphatase (RPAP) and the C-terminal phosphatase domain of the bifunctional
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Figure 1.12
Structure-based alignment of members of the histidine phosphatase family. The
helices and strands are indicated above the sequences. Residues identical in the four
sequences are shaded. Abbreviations: Yeast PGAM, S. cerevisiae PGAM (White and
Fothergill-Gilmore, 1988); Human BPGAM, bisphosphoglycerate mutase (E
isoenzyme) from human erythrocytes (Joulin et al., 1986); rat PAP, rat prostatic acid
phosphatase (Roiko et ah, 1990); rat F26BPase, fructose-2,6-bisphosphatase from rat
liver (Lively et ah, 1993). Figure from Rigden et al., 1997).
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have functional similarity with the mutases (Van Etten 1982, Bazan et al. 1989), and
the catalytic mechanisms involve a phosphohistidine intermediate. Together with the
phosphoglycerate mutases, they are sometimes known as the histidine phosphatase
family. The crystal structures of both RPAP and the recombinant C-terminal
phosphatase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase have
been solved (Schneider et al., 1993, Lee et al., 1996), and have been compared with
the 2.3A structure of S. cerevisiae PGAM (Rigden et al., 1997). Figure 1.12 shows a
structure-based alignment between S. cerevisiae PGAM, BPGAM from human
erythrocytes, RPAP and rat Fru-2,6-BPase. The catalytic site residues His8, His 181,
Arg7, Arg59 and Gly9 are conserved. Also conserved are residues which may be
involved in maintaining the tertiary structure of the enzymes. The structural
information, together with the results of site-directed mutagenesis studies on the
enzymes may give valuable insight into the mechanism of the related
phosphoglycerate mutases.
1.13.1 6-p/iosphofructo-2-kinase/fructose-2,6-bisphosphatase.
This bifunctional enzyme is responsible for the synthesis and hydrolysis of
fructose-2,6-bisphosphate (Fru-2,6-P2). This molecule, not itself an important
metabolic intermediate, acts as an allosteric modulator of two important enzymes in
sugar metabolism. An increase in cellular concentrations of Fru-2,6-P2 leads to
activation of 6-phosphofructo-l-kinase and inhibition of fructose-1,6-bisphosphatase.
A decrease in Fru-2,6-P2 reduces the activation of the kinase and the inhibition of the
bisphosphatase. These enzymes are usually considered to be rate-limiting in the
pathways of glycolysis and gluconeogenesis, and therefore an increase in Fru-2,6-P2
leads to a net increase of glycolysis versus gluconeogenesis (Pilkis et al. 1995).
The rat liver enzyme is a dimer, each subunit consisting of a single
polypeptide chain of 55,000 molecular weight. Residues 1-250 constitute the kinase
domain and 251-470 the bisphosphatase domain. This C-terminal domain has 36%
sequence identity with yeast PGAM. The crystal structure of the recombinant
bisphosphatase domain has been determined (Lee et al. 1996), and shows a similar
core structure to the yeast enzyme. The active site contains two histidines close to
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each other (4.2 A) but not parallel. Other key active site residues are conserved in
both the yeast PGAM and the bisphosphatase domain. A glutamic acid residue
(Glu86 in yeast PGAM, Glu 327 in fructose-2,6-bisphosphatase) has been shown by
site-directed mutagenesis to be important in the catalysis of the
fructose-2,6-bisphosphatase reaction (Lin et al. 1992). On the basis of these studies, a
mechanism has been proposed, involving nucleophilic attack by one of the histidines
(that corresponding to His8 in yeast PGAM) on the 2-phospho group of the substrate,
giving rise to the phosphohistidine intermediate The second His (corresponding to
His 181 in PGAM) donates a proton to the leaving group. The unprotonated Glu then
leads to the formation of a OH" ion from a water molecule, which then breaks down
the phosphohistidine by nucleophilic attack on the phospho group, producing a
molecule of inorganic phosphate.
1.13.2 Acid Phosphatases
The hydrolysis of phosphoric monoesters is catalyzed by several non-related
enzymes, of which the acid phosphatases are one group. A conserved sequence motif
in these enzymes is also found in phosphoglycerate mutase and in the phosphatase
domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (Roiko et al. 1990).
Crystallographic studies have shown that these enzymes have a similar core structure
(Schneider et al. 1993), and site-directed mutagenesis studies on the enzyme from
E. coli have shown that several residues which are located in the active site are
important for catalysis, including the two histidines, three arginines and an aspartate
(Ostanin et al. 1992). These, with further crystallographic studies on the rat prostatic
enzyme complexed with vanadate and molybdate (which are thought to act as
transition state analogues) have suggested a mechanism similar to that of the
bisphosphatase reaction of the bifunctional enzyme (Lindqvist et al. 1994).
Nucleophilic attack on the P atom of the phospho group of the substrate by an
unprotonated histidine leads to the cleavage of the P-0 bond. The oxygen atom of the
ester is protonated to prevent the formation of a high energy alkoxide species. There
are two candidates for the proton donor - a His residue analogous to that implicated
in the PGAM and Fru-2,6BPase, and an Asp residue. The low optimum pH and the
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orientations of these residues make the Asp (Asp258) the more likely donor, and the
His is presumed to have a role in substrate binding. The proposed mechanism for this
enzyme does therefore differ from those proposed for the other histidine
phosphatases discussed. If they are indeed homologous, it is likely that this change
occurred during adaptation to different conditions, in particular the change in the pH
at which the enzyme functions.
1.14 Background to the project and aims
The PGAM from S. cerevisiae is the most extensively characterized of all the
cofactor-dependent phosphoglycer'ate mutases. The availability of complete
nucleotide and aminoacid sequences and the X-ray crystal structure (the only
structure of a PGAM available) gave a good background for the study of this enzyme
using protein engineering techniques. An expression system was developed by Dr
Malcolm White, who constructed a phagemid vector carrying the pgm gene from S.
cerevisiae. The vector (pVT-gpm) is shown in figure 1.13. There are a number of
features which allow the production of single-stranded DNA for site-directed
mutagenesis, the transformation of yeast and overexpression of phosphoglycerate
mutase to be carried out without subcloning. The gene is under the control of its own
promotor, and is expressed in a strain of S. cerevisiae from which the chromosomal
copy of the phosphoglycerate mutase gene had been deleted and replaced with a
marker gene HIS3, thereby removing the possibility of comtamination by wild type
PGAM when mutant copies of the gene are expressed. Using this system, Dr White
constructed a number of mutants designed for use in investigating the roles of several
specific residues. Some of these were fully characterized, including a mutant in
which Hisl 81 was replaced with Ala (White and Fothergill-Gilmore, 1992, White et
al., 1993). However, several other mutants that were constructed had not been
characterized. These included a set of mutants where the C-terminal lysines were
replaced by alanines, which were designed to investigate the roles suggested for the
tail (see section 1.9.4). In addition, there was a set of mutants which were constructed














The phagemid vector pVT-gpm (White and Fothergill-Gilmore, 1992).
GPM: the phosphoglycerate mutase gene, expressed under its own promoter; ori:
origin of replication; ApR: ampicillin resistance for selection in E. coir, fl: phage
origin of replication for the production of single-stranded DNA; URA3: for selection
in S. cerevisiae.
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section 1.12, certain residues conserved in the monophosphoglycerate mutases differ
in the bisphosphoglycerate mutases. These include Serl 1 (Gly in BPGAM) and
Ala60 (Ser in BPGAM). The mutants have the residues of monophosphoglycerate
mutase replaced by the residues found in BPGAM. The primary aim of this project
was to express, purify and characterize these mutant enzymes. In addition, the role of
the C-terminal tail could be further studied using limited proteolysis, which has been
used previously to remove the C-terminal region of rabbit muscle PGAM (Price et al.
1985). During the course of this project, a final-year research project was undertaken
in this laboratory by four Honours students, who constructed a mutant in which
Glu86 was replaced with a glutamine. Subsequently, the mutant was overexpressed








TGI supE hsdAS thi A(lac-pro AB)
F'[traD36 proAB+ lacE lacZ AM 15]
CJ236 dut\ ung\ thi-\ relAl / pCJ105 (camr F')
S. cerevisiae:
S150-gpm::HIS3 MAT a, ura3, leu2, trpl, his3, gpm::HIS3
(White and Fothergill-Gilmore 1992).
2.1.2. Vectors
The following were made by Dr. Malcolm White.





Oxoid Ltd., Haverhill, Suffolk.
Tryptone, bacteriological peptone, yeast extract, agar No. 1.
Difco Ltd., Central Avenue, East Molesly, Surrey.
Yeast nitrogen base without amino acids.
Sigma Chemical Company, Fancy Road, Poole, Dorset.
Ampicillin, kanamycin, tetracyclin, tryptophan.
2.1.4. Radiochemicals
Amersham pic, Lincoln Place, Aylesbury, Bucks.
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Deoxyadenosine 5'-(a-3:,S)thiotriphosphate, triethylammonium salt, stabilized
aqueous solution >300Ci/mmol.
2.1.5. Plasmid preparation.
Qiagen Ltd. Unit 1, Tillingbourne Court, Dorking Business Park, Dorking,
Surrey.
Qiaprep-spin plasmid kit.
2.1.6. Enzyme Assays and Purification
Boeringher Mannheim, Bell Lane, Lewes, East Sussex.
Enolase, pyruvate kinase, lactate dehydrogenase, glyceraldehyde-3-phosphate
dehydrogenase, triose phosphate isomerase, aldolase, 3,4-dichloroisocoumarin,
fructose 1,6-bisphosphate, NAD, NADH, ATP, ADP.
Sigma Chemical Company, Fancy Road, Poole, Dorset.
3-phosphoglycerate grade I, 2,3-bisphosphoglycerate, 2-phosphoglycollate, E64.
Aldrich Chemical Company Ltd, New Road, Gillingham, Dorset.
1,10-phenanthroline.
BDH, Merck Ltd, Hunter Blvd, Magna Park, Lutterworth, Leics.
Polyethyleneimine.
0.5mm diameter glass beads.
Whatman, Maidstone, Kent.
QA52-cellulose.
Pharmacia Ltd, Midsummer Blvd, Central Milton Keynes, Bucks.




Northumbria Biologicals Ltd., South Nelson Industrial Estate, Cramlington,
Northumbria.
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T4 polynucleotide kinase, T4 DNA ligase.
Boeringher Mannheim, Bell Lane, Lewes, East Sussex.
RNase A.
Sigma Chemical Company, Fancy Road, Poole, Dorset
Lyticase.
2.1.8. Oligonucleotides
Synthesised by OSWEL DNA Service, Dept. Chemistry, University of Edinburgh,
West Mains Road, Edinburgh.
2.1.9. DNA Sequencing
Amersham pic, Lincoln Place, Aylesbury, Bucks.
Sequenase Version 2.0™ DNA sequencing kit




Amersham pic, Lincoln Place, Aylesbury, Bucks.
Hyperfilm MP X-ray film.
Sigma Chemical Company, Fancy Road, Poole, Dorset.
Polaroid 665 film
Millipore (UK) Ltd., Peterborough Road, Harrow, Middlesex.
Millex-GS 0.22pm filter units.
A & J Beveridge Ltd., Bonnington Rd Lane, Edinburgh.
15 and 50ml Falcon tubes.
All other chemicals supplied by BDEI or Sigma.
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2.2. METHODS
Note - unless otherwise specified, "yeast" refers to Saccharomyces cerevisiae.
2.2.1. Growth of yeast
Yeast can be grown in either a rich, non-selective medium or in a synthetic medium
which allows the selective growth of cells which can synthesize a specific amino acid
or nucleotide. For example, the strain of yeast used for expressing the mutant
PGAMs in this work, S150-2B GPM::HIS3, is ura3-, and can only grow in a
selective ura- medium if it has been transformed with a plasmid carrying a functional
URA3 allele (here the pVT-103U vector). Usually glucose is supplied as a carbon
source, but as S150-2B GPM::HIS3 cannot use the glycolytic pathway, it must be
grown on a non-fermentable carbon source. In this work glycerol and ethanol are
used. Using glucose instead of glycerol and ethanol in the plates after yeast
transformation therefore also acts as a selection for transformants, as
non-transformed cells would not be able to utilize this carbon source.
2.2.1.1 Growth Media
(Percentages are expressed as w/v)
YEPD Yeast extract 1%
Bactopeptone 2%
Glucose 2%




The above were made up to the desired volume with distilled water and sterilized by
autoclaving at 151b/in2 for 15 minutes. For YEPD/YEPGE agar, 2% agar was added
before autoclaving.
46
YOD ura- Yeast Nitrogen Base 0.67%
w/o amino acids
Casamino acids 1 %
Glucose 2%
YOGEura- Yeast Nitrogen Base 0.67%
w/o amino acids
Casamino acids 1 %
Glycerol 2%
Ethanol 2%
Casamino acids are the product of the hydrolysis of casein, and provide the necessary
amino acids to supplement the medium with the exception of tryptophan, which must
be added separately. A stock solution of 0.2% tryptophan was made up with distilled
water, sterilized by autoclaving and kept in the dark at 4°C. It was added to the
medium in a 100-fold dilution. For YOD/YOGE agar, 2% agar was added before
autoclaving.
2.2.2. Transformation of gpm-disrupted strain
A single colony of S150-2B GPM::HIS3 was transferred on a sterile loop to 5ml of
YEPGE and grown overnight at 30°C in a shaking incubator. This was then
subcultured into 50ml of fresh medium and grown to an OD600 of between 0.4 and
0.6.
The cells were harvested by centrifugation (4°C, 2000g, 5min), washed in 10ml TE
(lOmM Tris-HCl pH8.0, ImM EDTA pH8.0), and centrifuged again as before. The
washed cells were resuspended in 5ml LA (0.1M lithium acetate in TE).
20pl of miniprep DNA (approximately 4pg) was mixed with 200pl of cells. 300pl of
50% PEG4000 was added, mixed well and incubated at 30°C in a shaking incubator
for one hour. The cells were then subjected to heat shock at 42°C for 15 minutes.
The transformed cells were grown overnight in 3ml YEPGE, then spread onto
selective plates (YODura) and incubated at 30°C. Transformant colonies typically
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began to appear after 14 days. The transformation efficiency was low using the
deleted strain - typically 10-15 colonies from the above quantities.
2.2.3. Analysis of protein expression levels in yeast
The transformant colony was transferred on a sterile loop to 5ml YEPD and grown
overnight at 30°C in a shaking incubator. 1ml of the overnight culture was taken and
the cells pelleted by centrifugation (2500g, 2 minutes). The cells were resuspended in
70pl of 50mM Tris-HCl pH8.0 and glass beads (0.5mm diameter) were added to
l-2mm below the meniscus. The sample was cooled on ice for 5 minutes, then
vortexed twice for one minute with one minute cooling on ice in between. The cell
debris was pelleted by centrifuging the sample for 2 minutes at 12,000g. 20pl of the
supernatant was removed and analysed using SDS-PAGE.
2.2.4. Small-scale plasmid preparation from yeast
A single colony of the yeast was transferred on a sterile loop to 5ml of selective
medium (YODura) and grown overnight at 30°C in a shaking incubator. The
overnight culture was centrifuged (2500g, 2 minutes), and the supernatant was
discarded. The pellet was resuspended in 400pl of SCEM (1M sorbitol, 0.1M sodium
citrate pH 5.8, lOmM EDTA, 30mM 2-mercaptoethanol). 50 units of lyticase were
added and the sample was incubated for 20 minutes at 30°C. The level of spheroplast
formation was checked by mixing 5pl of cells with 5pl of 10% SDS and looking for
more than 50% lysis under a microscope. The spheroplasts were collected by
centrifuging at low speed for 10 seconds, and resuspended in 450pl of TE (lOmM
Tris.EICl pH7.5, ImM EDTA). 50pl of 10% SDS was added and the sample was
incubated for 30 minutes at 65°C. After incubation, 80pl of 5M potassium acetate
was added. The sample was kept on ice for one hour, then centrifuged (12,000g, 15
minutes) and the supernatant transferred to a clean tube. The plasmid DNA was
precipitated by the addition of 1ml of ice-cold ethanol and collected by centrifugation
(13,000rpm, 5 minutes). The pellet was rinsed with 0.5ml 70% ethanol and allowed
to air dry, then resuspended in 20pl of TE. lOpl was used to transform E.coli to
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allow sufficient amplification for analysis using agarose gel electrophoresis and
DNA sequencing.
2.2.5. Purification of S.cerevisiae phosphoglycerate mutase
NB - this method was followed for wild type mutase and all the mutants except
SI 1A/A60S.
2.2.5.1. Growth and cell lysis.
A single colony of the yeast expressing the PGAM to be purified was taken on a
sterile loop and used to inoculate 10ml of YEPD, and grown overnight at 30°C in a
shaking incubator. The following day this was used to inoculate 200ml of YEPD.
This was grown as before and used the next day to inoculate 2 litres of YEPD in four
2L flasks. The cells were harvested in early stationary phase (after approximately 18
hours' growth) by centrifugation. The cells were washed in a small volume of
ice-cold 50mM Tris-HCl pH8.0 and collected by centrifugation (2000rpm, 10
minutes, 4°C). The packed cell volume was estimated and the cells were resuspended
in an equal volume ice-cold 50mM Tris-HCl pH8.0. Protease inhibitors (see section
2.2.6.7) were added. The cell suspension was transferred to the pre-cooled chamber
of the bead-beater apparatus and an equal volume of 0.5mm diameter glass beads was
added. The cells were lysed by five one minute pulses with one minute cooling on ice
in between each pulse. The beads were then washed in ice-cold 50mM Tris-HCl
pH8.0 and allowed to settle out. The supernatant was centrifuged at 30,000g at 4°C
for one hour in an ultracentrifuge to remove cell debris, and the supernatant
collected.
2.2.5.2. Ammonium sulphate fractionation.
Solid ammonium sulphate was added to the cleared lysate to 50% saturation, slowly
and with stirring. This was carried out at room temperature (18-20°C). The sample
was centrifuged (17,400g, 30min, 4°C), the supernatant collected and ammonium
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sulphate added to 80% saturation. The sample was then centrifuged as above and the
pellet resuspended in 15ml lOmM Tris-HCl pH8.0 and dialysed against 5 litres of
lOmM Tris-HCl pH8.0 overnight at 4°C.
2.2.5.3. Anion exchange chromatography
The dialysed sample was applied to a QA52-cellulose column (20cm x 1.7cm2)
equilibrated overnight with 10mM Tris-HCl pH8.0 at 4°C. Wild type PGAM,
K245G, K246G, K245G/K246G and A60S bound to the column under these
conditions, and were eluted with a 500ml linear gradient of 0 - 75mM NaCl in lOmM
Tris-HCl pH8.0. The flow rate was approximately one column volume per hour.
S11A did not bind to the QA52-cellulose column under these conditions and was
collected when the column was washed with lOmM Tris-HCl pH8.0.
2.2.5.4. Size exclusion chromatography
The fractions showing peak mutase activities were pooled and further purified by
FPLC gel filtration on a Superose HR12 column equilibrated in 50mMTris-HCl
pH8.0, using a flow rate of 0.3ml/min.
The purified protein was analysed using SDS-PAGE and enzyme activity assays.
2.2.5.5. Partial Purification ofS11A/A60S
The cells were grown and lysed as for wild type mutase, but the buffer used was
30mM Tris.HCl pH8.0 containing 25% glycerol. The cell debris was spun out at a
lower speed (17,400g, 20 min, 4°C).
An equal volume of 0.2% polyethyleneimine, 25% glycerol (pH adjusted to 8.0) was
added and the mixture stirred for 30 minutes at 4°C. After centrifugation (17,400g,
30minutes) the supernatant was loaded directly onto a QA52-cellulose column




The following inhibitors were added to the cell slurry to prevent the degradation of
PGAM by endogenous proteases released when the cells were disrupted.
- 3,4-dichloroisocoumarin (inhibits serine proteases)
Stock - 5mM in DMSO. Diluted x 50 for use into the lysis buffer.
- E64c (inhibits cysteine proteases)
Stock - ImM in SDW. Diluted x 50 for use
-1,10-phenanthroline (inhibits metalloenzymes)
Stock - lOOmM in DMSO. Diluted x 1000 for use.
2.2.6. Purification of S.pombe phosphoglycerate mutase.
The sample of S.pombe PGAM was obtained in a partially purified condition from
Dr. J. Nairn, Department of Biological and Molecular Sciences, University of
Stirling, Stirling FK9 4LA. It was purified to homogeneity by a Superose 12 gel
filtration step, exactly as described for the S.cerevisiae PGAM in section 2.2.6.4.
2.2.7. Protein assays
The concentration of total protein in crude samples was determined by a Coomassie
Blue binding method (Sedmak and Grossberg, 1977), using bovine serum albumin as
a standard.
The concentration of pure enzyme was determined spectrophotometrically, using a
value of 1.45 for the A280 of a lmg/ml solution (Edelhoch et al., 1957).
2.2.8. Enzyme Activity Assays
2.2.8.1 Mutase assay
The mutase activity was coupled to the activity of enolase, pyruvate kinase and
lactate dehydrogenase.
The reaction was monitored by the decrease in absorbance at 340nm due to the
oxidation of NADH in the reaction catalyzed by lactate dehydrogenase.
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The activity was monitored using a Phillips 8720 UV/VIS spectrophotometer.
1 unit of PGAM was defined as lpmol NADH oxidized/min/mg PGAM





















0.5 units pyruvate kinase
0.5 units lactate dehydrogenase
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The concentrations of 3PGA and 2,3BPGA could be varied. Saturating
concentrations (5mM 3PGA, 0.2mM 2,3BPGA) were used when assaying for
specific activity,
The above components were mixed and allowed to equilibrate at 30°C for 5 minutes.
The reaction was started by the addition of PGAM.
For pure wild type PGAM, 20-50ng can conveniently be assayed, giving an activity
of approximately lOOOU/mg. Mutase samples were diluted in 30mM Tris.HCl pFI7.0
containing lmg ml"1 bovine serum albumin.
2.2.8.2 Phosphatase assay
The phosphatase activity was coupled (like the mutase activity) through enolase,
pyruvate kinase and lactate dehydrogenase.
The assay was carried out in 30mM Tris-HCl pH8.0, and KC1 and 3PGA were
omitted, otherwise the conditions were as for the mutase assay.
10-20pg of pure wild type PGAM can conveniently be assayed, giving a specific
activity of approximately 0.002U/mg.
2.2.8.3 Synthase Assay
The synthase activity was measured using the method of Rosa et al., 1989.
It is coupled to the activities of aldolase, triosephosphate isomerase (TIM) and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and followed by monitoring
the increase in absorbance at 340nm due to the reduction of NAD+ by GAPDH.









The above components were mixed and allowed to equilibrate at 30°C for 5 minutes.
The reaction was started by the addition of PGAM.
10-20pg of pure wild type PGAM can conveniently be assayed, giving a specific
activity of approximately 0.002U/mg.
2.2.9. Kinetic analysis.
The kinetic parameters of the enzyme were measured by varying the concentrations
of 3-PGA and 2,3-BPGA in the assay mixture, measuring rates and plotting them on
a Hanes plot, as described in Cornish-Bowden, 1979. Each assay was repeated in
triplicate and the data point shown is the mean of the three values obtained (which
differed by less than 5% standard error). The graphs were drawn using the
application Cricketgraph on an Apple Macintosh computer, which provided linear
regression analysis of the data. For each line of best fit, the R2 value obtained was
greater than 0.96.
2.2.10 Inhibitor studies.
The effect of inhibitors on mutase activity was carried out as described in section
2.2.8.1. 3-PGA was added to the assay mix at 5mM, and the concentrations of
2,3-BPGA and inhibitor were varied. The amount of coupling enzymes was doubled
(0.16 units enolase, 1 unit pyruvate kinase, 1 unit lactate dehydrogenase per assay).
See section 5.3. These were incubated at 30°C for five minutes, and the reaction was
started by the addition of PGAM. The results were plotted and regression analysis
performed using Lotus 123 for Windows.
2.2.11. Protein crosslinking
The subunits of PGAM were cross-linked with glutaraldehyde using the method of
Jaenicke and Rudolf (1986). 40pl of 25% (w/v) glutaraldehyde (Sigma Grade 1) was
added to a 1ml solution containing 10-50pg of protein in 50mM sodium phoshpate
buffer pH7.0. After two minutes at room temperature the reaction was quenched by
the addition of 50pl of 2M sodium borohydride in 0.1 M NaOH, and incubated for 20
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minutes at room temperature. After incubation, 3p,l of 10% aqueous sodium
deoxycholate was added, followed by 45pi of 78% trichloroacetic acid, added slowly
to minimize bubbling. The mixtures were incubated for five minutes on ice, and then
centrifuged for 10 minutes at full speed in a microcentrifuge at 4°C. The supernatant
was discarded and the pellet was washed in 600pl of cold acetone, dispersed with a
pipette tip, and centrifuged again as before. The supernatant was discarded and the
pellet resuspended in lOpl of loading buffer (0.1M Tris-HCl pH8.0, 0.1% SDS,
50mM DTT, 10% glycerol, 5mg/100ml bromophenol blue). The samples were
electrophoresed on a 15% SDS-PAGE gel.
2.2.12 Limited proteolysis
The proteolysis of PGAM by thermolysin was studied at 20°C in 50mM Tris-HCl
pH8.0. Solutions of thermolysin were prepared fresh each day in the same buffer. For
studying the effect of proteolysis on activity, thermolysin was added at different
concentrations to a lOOpg/ml solution of PGAM, and samples removed at intervals
and diluted into buffer containing 5mM EDTA to inactivate the thermolysin (Girg et
al. 1981). For studying the proteolysis using SDS-PAGE, 500pg/ml of PGAM was
incubated with thermolysin at 200pg/ml and 50pg/ml. Samples were removed at
intervals and EDTA added to 5mM. The samples were electrophoresed as detailed in
section 2.2.19.
2.2.13 Protein Sequencing
Sequencing studies on S. cerevisiae PGAM were done on an Applied Biosystems
477A microsequencer. Samples containing approxiamately 1 nmol of PGAM were
taken at zero time and after a ten minute treatment with thermolysin and spotted
directly onto glass fibre disks for sequencing.
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2.2.14 Circular Dichroism.
C.d. measurements were performed on a JASCO J-600 spectropolarimeter at 20°C.
The molar ellipticities were calculated assuming a value of 112 for the mean residue
weight of each enzyme (White and Fothergill-Gilmore, 1988).
2.2.15 Mass Spectrometry
Mass spectrometry analysis was performed on a VG Platform quadropole mass
spectrometer (2-3000 amu range) fitted with a pneumatically assisted electrospray
source and controlled via the VG Mass-Lynx software (VG Biotech Ltd, Altrincham,
Cheshire, UK.).
2.2.16 Site-Directed Mutagenesis
Site-directed mutagenesis was carried out using the method of Kunkel (1987). The
single-stranded template was prepared from CJ236 cells transformed with pVT-gpm
using the standard methods described above. The helper phage used in production of
single-stranded DNA was M13K07. Sequenase version 2.0 purchased from
Amersham was used as the DNA polymerase, and the method given in Sambrook et
al. (1989) for mutagenesis using this enzyme was followed. The mutagenesis
reaction mix was used to transform competent TGI cells. The resulting colonies were
then pooled and grown overnight. Plasmid DNA was then prepared from the pooled
cells and again used to transform TGI. This ensured that a single colony only
contained either a wild type or a mutant copy of the plasmid. The colonies were then
screened for mutants using DNA sequencing.
2.2.17 DNA sequencing.
Sequencing was done using the Sequenase version 2.0 kit from Amersham, using the
modifications described in Hsaio (1991) for a double stranded DNA template.
The reactions were electrophoresed on a 6% acrylamide/urea gel made up using
Sequagel solutions from Flowgen Instruments Ltd. The gel was fixed and dried and
an autoradiograph obtained using the standard procedure given above.
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2.2.18 Standard Procedures.
The following procedures were carried out as described in Molecular Cloning - A
Laboratory Manual (Second Edition). Sambrook, J., Fritsch, E.F. & Maniatis,
T.(l989) Cold Spring Harbour Laboratory Press.
♦ Preparation and purification of single-stranded phagemid DNA.
♦ Extraction and purification of plasmid DNA from E.coli. (To obtain high qual¬
ity templates for DNA sequencing, the Qiaprep spin plasmid kit from Qiagen
was used)
♦ Preparation and transformation of competent E.coli using calcium chloride.
♦ Autoradiography of Sequencing gels.
♦ SDS-polyacrylamide gel electrophoresis of proteins.
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Chapter Three




The susceptibility of proteins to proteolysis has been widely used to study
their domain structures. Particularly susceptible are "flexible loops" in the
polypeptide chain. As described in section 1.8.4 the 14 residues nearest the
C-terminus of phosphoglycerate mutase from S.cerevisiae are not seen in the electron
density map and are therefore assumed to form one of these highly flexible regions
(Winn et al. 1981).
Early attempts to purify the enzyme from yeast gave a mixture of enzyme
forms with differing electrophoretic mobilities (Chiba and Sugimoto 1959, Chiba et
al. 1960a). The component with the lowest electrophoretic mobility had the highest
specific activity and vice versa. Chiba et al. (1960b) showed that the formation of the
lower activity components was dependent on the length of time the yeast was
subjected to autolysis during enzyme purification. The endogenous protease was
partially purified by Sasaki et al. (1966) and was shown to cause the loss of nine or
ten residues per subunit of PGAM. Comparison of the amino acid composition of the
native and modified enzyme showed that they were similar, but that the proteolyzed
protein contained less alanine, lysine, glycine, valine, aspartic acid and glutamic acid.
The difference between the two corresponded closely to the number of residues
liberated during modification. Alanine, glycine, lysine and valine are all found at the
C-terminus of the protein (the tail region). Removal of these residues did not alter the
optical rotary dispersion pattern of the enzyme, and although the mutase activity was
severely affected, the 2,3BPGA phosphatase activity was unchanged. This activity
was not however stimulated by the substrate analogue 2-phosphoglycollate in the
modified enzyme, compared with the 20-fold increase seen with the native enzyme.
More recently, the enzyme from rabbit muscle has been shown to be
inactivated by limited proteolysis with thermolysin (Price et al. 1985). Again the
inactivation was not accompanied by a change in overall conformation as measured
using circular dichroism, although when analyzed using SDS-PAGE, a change in
electrophoretic mobility was seen, which was thought to be due to the loss of a
peptide corresponding to the C-terminal tail of the yeast enzyme.
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Similar experiments were done on the yeast enzyme to try to elucidate the role of the
tail.
3.2 Effect of different thermolysin concentrations on mutase
activity
PGAM (lOOpg/ml) was incubated with various concentrations of thermolysin
(0, 10, 50 and lOOpg/ml) and samples removed at intervals. These were assayed for
mutase activity, and the results are shown in figure 3.1. Clearly thermolysin has a
significant effect, with activity lost rapidly over the first 10-20 minutes and
continuing to decrease at a slower rate for at least 2 hours. When the reaction is
complete (i.e. the activity no longer changes with time) around 10% of activity
remains. This pattern is seen for all concentrations of thermolysin, with the higher
concentrations reaching this level more quickly.
Further investigations were carried out using the 10:1 PGAM to thermolysin ratio.
3.3 Effect on phosphatase activity
The phosphatase activity is largely unaltered by treatment with thermolysin,
as can be seen in figure 3.2. However, the stimulatory effect of 2-phosphoglycollate
is decreased, from 18-fold with untreated PGAM to 1.8 fold after 2 hours incubation.





mutase 970 630 95








Specific activities (units, see 2.2.8.1) of untreated and proteolyzed PGAM from S.










The effect of thermolysin on the mutase and phosphatase activities of PGAM. PGAM
was added at lOOpg/ml and thermolysin at 10pg/ml.
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3.4 Effect of thermolysin on PGAM monitored by SDS-PAGE
Figure 3.3 shows the pattern seen on SDS-PAGE when 500pg of PGAM was
treated with 200pg thermolysin. A second band (with higher electrophoretic
mobility) becomes visible after 10 minutes, becoming more prominent with time.
However, the total amount of protein present clearly decreases, and almost no protein
is visible after 120 minutes. When the 10:1 PGAM to thermolysin ratio was used
(Figure 3.4), again a second band appears (after 20 minutes), but the band
corresponding to native PGAM remains the major component. As this does not
correlate with the large decrease in activity observed, it is unlikely that this band is
the tailless enzyme (see Section 3.6).
3.5 The effect of ligands
Limited proteolysis was carried out as before, but with the addition of
saturating concentrations of substrates 3PGA and 2,3BPGA (lOmM and 0.5mM
respectively - the concentrations used in the standard activity assays). The results can
be seen in figure 3.5. In the presence of 3PGA alone, the loss of activity seen over
time was very similar to that seen when no substrates were added. However, when
2,3-BPGA was included (either alone or with 3PGA), the initial decrease in activity
(over 20 minutes) was seen to be slower, whereas the more gradual decrease from 30
minutes to 2 hours was at approximately the same rate.
3.6 Separation and sequencing of peptides
The 2 hour sample was run on a reverse phase hplc column, and a complex
pattern of many peptides emerged, suggesting more than a single clip near the
C-terminus (see figure 3.6). One of the largest peaks (fraction 23) was subjected to




SDS-PAGE analysis of the effect of thermolysin on PGAM.
500|ag/ml PGAM, 200}ig/ml thermolysin.
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Figure 3.4
500|ag/ml PGAM, 50jxg/ml thermolysin.








Peptides eluted from a 2.1 mm x 30 mm, reverse phase C18 Aquapore RP300 hplc
column after incubating PGAM and thermolysin in a 10:1 ratio for 2 hours. The most
abundant peptide (peak 23) was collected and sequenced.
(Applied Biosystems Microbore hplc system, model 130.)
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This corresponds with the internal sequence of residues 115-124. Taken together
with the number of peptides generated, this suggests that thermolysin is attacking at
sites other than the tail. These results were obtained with the sample incubated with
thermolysin for 2 hours, however most of the loss of activity occurs within 20
minutes, and it is not until this time that the second band appears on the SDS gel. It is
possible that the clipping of the readily available tail could account for the initial
sharp decline in activity, and then further cleavages elsewhere on the protein which
give rise to the subsequent slow activity loss and the protein species with higher
electrophoretic mobility.
3.7 Sequence analysis of the complete incubation mixture
N-terminal sequence analysis was done on the complete incubation mixtures
at zero time and at 10 minutes.
6 cycles of the zero time incubation gave the following 2 sequences:
Sequence initial yield identity
P KL VL V 400pmol PGAM residues 1 -6
I T G T S(?)T 80pmol thermolysin residues 1-6
(?) indicates that the residue cannot be assigned unambiguously.
After 10 minutes, the sequences above were seen in the same yields, and also
a third sequence:
V A N Q G K(?) 500pmol PGAM residues 240-245
As is usual with small peptides, the yields fell away significantly between
cycles as the peptide is washed off the disc in the sequencer. The yields for the larger
fragments remained more constant.
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If all PGAM molecules lost the 7 residue peptide within 10 minutes, the
initial yield of peptide would be expected to be equal to the initial yield for the
protein's N-terminal sequence. Given the activity results, it is unlikely that this is the
case. Obviously 400pmol of PGAM cannot yield 500pmol of peptide, but it is known
that certain residues such as proline give low yields in N-terminal sequencing. Valine
by contrast, is typically recovered in very high yield.
3.8 Proteolysis studied by Mass Spectroscopy
The removal of these 7 residues was confirmed using electrospray mass
spectroscopy. The results are shown in figure 3.7.
At zero time, the major peak is at a mass of 27,475 (the intact PGAM monomer),
and there is is a much smaller peak at 26,748. After 5 minutes the lower mass peak is
the most abundant, and after 15 minutes the peak corresponding to the intact
monomer has disappeared.
The difference between these two masses (727) corresponds to the loss the of the 7
C-terminal residues ( V A N Q G K K).
N.B. The presence of the small lower mass peak in the zero time sample is probably
due to the delay in loading the sample into the machine (i.e. zero time is not exactly
zero time).
3.9 Discussion
Previous experiments on PGAM from rabbit muscle have indicated that a
portion of that enzyme which corresponds to the flexible C-terminal tail of the yeast
PGAM can be cleanly removed by treatment with thermolysin. Attempts to replicate
this simple removal of the tail from the yeast enzyme have not been completely
successful. The digestion of PGAM by thermolysin can be divided into two main
stages. Immediately on addition of the protease, a seven residue peptide is removed
from the C-terminus, which leads to a significant decrease in the level of mutase
activity. The removal of the peptide is confirmed by peptide sequencing and mass
spectrometry. It does not however give rise to an obvious change in electrophoretic
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Figure 3.7
Results obtained from mass spectrometry at 0 min incubation.
The mass of each fragment detected is given above the peak.
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Figure 3.8
Results obtained from mass spectrometry at 5 min incubation..
The mass of each fragment detected is given above the peak.
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mobility. The second stage begins after about five minutes incubation, and involves
more extensive proteolysis, giving rise to a number of peptides as seen on the HPLC.
This degradation also leads to a decrease in mutase activity, although less dramatic
than that observed with the loss of part of the tail. Throughout, the phosphatase
activity remains fairly constant, and so it is unlikely that the tail is involved in
catalysing this reaction.
These results clearly show the importance of the tail in the mutase reaction.
The protein sequencing and mass spectrometry results show that the initial loss of
over 60% of activity is due to the removal of a seven residue peptide from the
C-terminus only - the rest of the enzyme remains intact. This peptide represents the
majority of the highly flexible region of the tail beyond the short helix seen in the
new 2.3A structure (see figure 1.8), and therefore this region is crucial in maintaining
a high level of mutase activity. It is not however important in maintaining the
phosphatase activity. It has also been proposed that the tail is responsible for
maintaining a low level of phosphatase activity by excluding water from the active
site, thereby preventing the hydrolysis of the phospho enzyme and the transfer of the
phospho group to water (see section 1.8.4). However, if this were the case, we would
expect to see the removal of a significant proportion of the tail accompanied by an
increase in the phosphatase activity. In fact, the phosphatase activity remains almost
constant during removal of the tail.
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Chapter Four
The Role of the C-terminal Lysine Residues
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4.1 Introduction
As described in section 1.8.4, the two C-terminal residues of the S. cerevisiae
mutase are lysine (K245 and K246). These are therefore at the end of the C-terminal
tail - the region not seen in the electron density map of PGAM and assumed to be
flexible. The position of one of the lysines (K245) is conserved in most PGAM
sequences (bis- and monophosphoglycerate mutases) with the exception of the S.
pombe PGAM, which lacks the residues thought to constitute the tail.
Figure 4.1. The C-terminal regions of PGAMs from different organisms.
ef. S.cerevisiae
numbering
233 234 235 236 237 238 239 240 241 242 243 244 245 246
1 S. cerevisiae A A A G A A A V A N Q G K K
2 S.coelicolor A A A A I E A V K N Q G K. K K
3 E.coli I A A K A A A V A N Q G K A K
4 human-B V R K A M E A V A A Q G K A K K
5 human-M V R K A M E A V A A Q G K A K
6 rat-B V R K A M E A V A A Q G K V K K
7 rat-M V R K A M E A V A A Q G K A K
8 human-E I Q A A I K K V E D Q G K V K Q A K K
9 rabbit-E I Q A A I K K V E D Q G K V K. R A E K
Human E-type 239 240 241 242 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258
numbering
In order to investigate the role of the C-terminal lysines of S.cerevisiae
PGAM, a number of mutants had been constructed previously by Dr. Malcolm White
and expressed in the gpm-disrupted strain as described in section 1.14. The mutants
have the lysines replaced with glycines which are neutral and therefore have different
charge properties to the wild type enzyme.
Figure 4.2 The C-terminal sequences of the lysine tail mutants, showing charges,
wild type -AAAVANQGKT K+coo.




This chapter describes the purification and characterization of these mutants.
4.2 Expression of the tail mutants.
The wild type and mutant proteins were expressed in the gpm-disrupted strain
of S. cerevisiae. All grew on YEPD, using glucose as a carbon source, which
demonstrates that the mutant PGAMs do show some mutase activity. After overnight
growth, the yeast was lysed using glass beads and the proteins run on an SDS-PAGE
gel (Figure 4.3). Wild type and mutant PGAM proteins were expressed to high
levels. The wild type, K246G and K245G/K246G proteins represented around
20-30% of total cell protein, as estimated from the SDS-PAGE gel. The K245G
protein was expressed to a lesser extent. It was thought that perhaps the phagemid
had established at a lower copy number than usual in the original colony. Different
transformants may express to a higher level, so the pVT-K245G phagemid was used
to transform the disrupted strain again. Several transformants were screened, but
each showed a similar level of expression (see figure 4.4.).
4.3 Growth of the tail mutants
The growth characteristics of the wild type and mutant strains were
investigated. Growth curves are shown in Figure 4.5. There are no significant
differences between wild type and mutants. The mutase gene carried on the
phagemid is overexpressed, so a decrease in activity would not necessarily cause the
cells to grow more slowly as the increased number of PGAM molecules could
balance the lower activity. Flowever, it has been shown previously that where the
change in activity is very great, there can be changes to parts of the growth curve, as
for the active site H181A mutant (White and Fothergill-Gilmore, 1988).
4.4 Purification of wild type and tail mutants
The wild type and mutant proteins were purified as described in Section 2.2.6.




12% SDS-PAGE showing the levels of expression of the wild type and mutantPGAM (see section 2.2.3)
Lane 1 S150-2B GPM: :HIS3 + pVT-gpm2 S150-2B GPM: :HIS3 + pVT-K246G
3 S150-2B GPM::HIS3 + pVT-K245G











Growth curves for S150-2B GPM::HIS3 expressing wild type or mutant PGAM.
An overnight culture of each was used to innoculate 500ml YEPD (section 2.2.2.1) to
0.1 OD600. This was then incubated (with shaking) at 30°C, and small samples taken
at intervals to determine optical density. Each point represents the mean value
obtained from three cultures.
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PGAM (White and Fothergill-Gilmore 1992), with the addition of a final FPLC
Superose 12 gel filtration step. Each protein was purified to homogeneity as indicated
by a single band on an SDS-PAGE gel (see Figure 4.6).
Proteolytic degradation of yeast PGAM during purification is
well-documented (Sasaki et al. 1976) and it is thought that the tail is particularly
susceptible. Care must be taken at every stage to ensure that the enzyme is purified
intact, especially when a study of the role of specific tail residues is being
undertaken! A combination of inhibitors shown to be effective in previous work
(White and Fothergill-Gilmore, 1989, details of inhibitors given in section 2.2.6.7)
was added before cell lysis. The preparations were kept on ice in between steps and
most steps were carried out at 4°C. The final gel filtration step had to be carried out at
room temperature because it involved the use of an FPLC system. Flowever, this step
is very quick (PGAM elutes from the column in less than two hours) and did not









Total EU EU/mg Yield % Fold
purification
lysate 250 1,225 425,000 347 100 1
dialysate 100 590 350,000 593 82 1.7
QA52- cellulose 56 73 44,800 615 11 1.8
Superose 12 5 40 40,500 1,013 10.5 3
Table 4.1
Purification of wild type PGAM from S. cerevisiae. EU (enzyme units) defined as
pmol NADH oxidized/min.
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Figure 4.6
12% SDS-gel of purified wild type and mutant phosphoglycerate mutases.












Total EU EU/mg Yield % Fold
purification
lysate 255 1,097 372,810 340 100 1
dialysate 100 500 240,000 430 64 1.4
QA52- cellulose 63 58 34,970 603 9.4 1.8
Superose 12 4.5 38 32,300 850 8.7 2.5
Table 4.2













lysate 250 1,134 238,140 210 100 1
dialysate 100 525 181,125 345 76 1.6
QA52- cellulose 59 80 37,120 464 16 2.2
Superose 12 5 42 23,730 565 10 2.7
Table 4.3













lysate 245 1,010 270,545 268 100 1
dialysate 100 460 202,909 441 73 1.6
QA52- cellulose 56 51 40,582 796 15 2.9
Superose 12 4.5 32 29,760 930 11 3.5
Table 4.4
Purification of K245G/K246G PGAM. EU (enzyme units) defined as pmol NADH
oxidized/min.
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The yield was consistently around 10% as not all the fractions in the mutase
peak eluting from the QA52-cellulose column were pooled and taken on to the next
step. The decision was taken to sacrifice some of the yield in this step in order to
collect a purer sample which could be purified to homogeneity on the Superose 12
column. When all the fractions showing mutase activity were pooled, at least one
other protein was also collected which could not be separated from PGAM on the
gel filtration column. As the mutase is so overexpressed, even a 10% yield gave tens
of milligrams of protein, sufficient for most purposes.
4.6 Storage and stability of phosphoglycerate mutase
The PGAM was eluted from the Superose column in 50mM Tris.HCl pH8.0.
Wild type PGAM is stable in this buffer for at least one week when stored at 4°C,
after which time activity begins to decrease slowly (a graph showing wild type
activity over 20 days is given in figure 6.7). For longer term storage, the enzyme is
kept in 80% saturated ammonium sulphate at 4°C. Under these conditions it is stable
for at least two months. The K246G, K245G and K245G/K246G mutants do not
show any significant differences to wild type mutase in storage and stability.
4.7 Circular Dichroism Spectra
The mutants had very similar far u.v and near u.v spectra to the wild type
(Figures 4.7 and 4.8), indicating that the mutations had very little effect on the
secondary and tertiary structure of the enzyme.
4.8 Specific activities




Far u.v. spectra of wild type and mutants.




Near u.v.spectra of wild type and mutants.
Key: Green, wild type; Red, K246G; Black, K245G; Blue, K245G/K246G.
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mutase EU/mg phosphatase EU/mg synthase EU/mg
WT 970 0.02 0.01
K246G 850 0.02 0.02
K245G 565 0.02 0.02
K245G/K246G 930 0.02 0.02
Table 4.5
Specific activities of wild type, K245G, K246G and K245G/K246G PGAM. EU
(enzyme units) defined as prnol NADH oxidized/min. All values are determined
from three different experiments and given as means with less than 5% standard
error.
The mutants show mutase activity of between 60 and 100% of the wild type,
and phosphatase and synthase activities are apparently almost unaltered. However,
with such low levels of activity, changes are difficult to detect accurately.






wild type 0.02 0.35 18
K246G 0.02 0.39 16
K245G 0.02 0.09 4.1
K245G/K246G 0.02 0.09 4.0
Table 4.6
The stimulatory effect of 2-phosphoglycollate (2-PG) on the phosphatase activity of
wild type, K246G, K245G and K245G/K256G PGAM. The activities are given as
EU (defined as pmol NADH oxidized/min).
The stimulation of the K246G mutant is similar to the wild type enzyme, but




The Km values for 3-PGA and 2,3-BPGA in the mutase reaction were
determined for the wild type and each mutant. Hanes plots are shown in Figures 4.9 -
4.12. All show ping-pong kinetics as described for the wild type. The kinetic data are
shown in the table below.
Km3"PGA pM KmBPGA pM k s"1'Vat 3
wild type 470 3.2 530
K246G 630 3.2 520
K245G 400 2.4 210
K245G/K246G 1,430 7.9 560
Table 4.7
The kinetic constants of wild type, K246G, K245G and K245G/K246G PGAM,
calculated using Hanes plots.
The results for wild type are in close agreement with previously published
values (White and Fothergill-Gilmore 1992).
4.10 Limited proteolysis
The interaction of the tail lysines with substrates was further studied using the
limited proteolysis by thermolysin described in chapter three. The effect of
thermolysin concentration on the activity of K245G/K246G was measured (Figure
4.13B) and is similar to the pattern seen with wild type (see Figure 4.13A). The
mutant is however affected more quickly than the wild type at all concentrations of
thermolysin.
Wild type and mutant PGAMs were incubated with concentrations of
substrate used in specific activity assays (10mM 3-PGA and 0.5mM 2,3-BPGA) and
subjected to limited proteolysis. For wild type PGAM, the addition of 3-PGA does
not have any significant effect on the extent of proteolysis. When 2,3-BPGA is added
however, the rate of activity loss is decreased and indeed never reaches the same
















Hanes plots showing kinetic data obtained for wild type PGAM. The pattern seen in
the primary plot corresponds to a ping-pong mechanism. The inset graph is the
secondary plot required for calculating the kinetic constants. Assays were carried out


























































































The effect of different concentrations of thermolysin on the activity of A. Wild type
PGAM and B. K245G/K246G. The concentration of mutase was 1OOpg/ml.
Figure A is reproduced here from chapter three in order to facilitate close comparison
with the results for the mutant.
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activity remaining as opposed to around 25%). When the same experiments are
carried out with the K245G/K246G enzyme, this pattern is not repeated; the addition
of ligands has no significant effect on the extent of activity loss due to proteolysis
(see Figure 4.14). In addition, the inactivation is more rapid with the mutant, which
suggests that it is more susceptible to proteolysis.
4.11 Discussion
The mutase, phosphatase and synthase activities are all unaffected by the
replacement of the C-terminal lysines. In addition, the kinetic constants for the wild
type and mutants are also similar. Where both lysines are replaced (leaving an overall
negative charge at the C-terminus), the KM values for 2,3-BPGA and 3-PGA are
slightly higher than with the wild type enzyme (3x and 2.5x wild type values
respectively), although none of the differences are consistent with crucial charge
interactions with negatively charged phospho groups of bound substrates or
intermediates that have previously been suggested (Fothergill-Gilmore and Watson,
1989). However, some degree of interaction with the bisphosphoglycerate substrate
bound to the enzyme is suggested by the results of the limited proteolysis
experiments.
As has been previously shown with the rabbit muscle enzyme (Price et al.
1985), the presence of 2,3-BPGA offers some protection against thermolysin for the
wild type enzyme. It suggests that the tail adopts a less flexible conformation when
this molecule is bound in the active site. 3-PGA does not have this protective effect,
indicating that both phospho groups are necessary to draw the C-terminus towards
the active site in this way. No ligand protection is seen in the K245G/K246G mutant,
either with 3-PGA or 2,3-BPGA. As would be expected then, the positive charge
associated with the C-terminal lysines is necessary for the interaction between
enzyme-bound BPGA and the tail.
Another difference between the mutants and wild type is seen in the
enhancement of phosphatase activity in the presence of the substrate analogue

























The effect of ligands on the limited proteolysis of wild type PGAM (A) and
K245G/K246G (B).
PGAM at lOOpg/ml, thermolysin at 10pg/ml.
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analogue binding to the phosphorylated enzyme along with a molecule of
water,facilitating the transfer of the phospho group to water. The stimulated activity
when lysine 245 is replaced is only a quarter of that observed for the wild type and
K246G enzymes. The positive charge associated with the C-terminus therefore
appears to be important for the maximal stimulatory effect of 2-phosphoglycollate.
The role of the C-terminal tail can also be investigated by comparing the
properties of the enzyme from S. cerevisiae and that from the fission yeast S. pombe
which lacks the residues that constitute this region. The S. pombe enzyme catalyzes
the mutase reaction with a significantly lower mutase activity than the S. cerevisiae
mutase (210 pmol/min/mg compared with 970 pmol/min/mg). The phosphatase
activity is about 3x higher than the S. cerevisiae PGAM, but still significantly lower
than the mutase activity. The ratios of phosphatase and mutase activites are given in
the table below.
Specific activities (pmol/min/mg)




S. cerevisiae 970 0.02 0.35 (18) 2.1
PGAM




S. pombe 220 0.06 0.14(2.3) 28
PGAM
Table 4.8
Specific activities of S. cerevisiae and S. pombe PGAM, and the ratios of
phosphatase to mutase activities. Values for S. pombe PGAM are taken from Nairn et
al, 1996.
The results from the S. pombe mutase are in agreement with the results for the
proteolyzed S. cerevisiae mutase. They support the the conclusion that the residues
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found in the tail are responsible for the maximal stimulatory effect of
2-phosphoglycollate on the phosphatase activity. The levels of phosphatase activity
are very low compared to the mutase activity, even in the absence of the tail. It is
therefore unlikely that the exclusion of water by the tail is responsible for the low
phosphatase activity of S. cerevisiae PGAM, as has been suggested
(Fothergill-Gilmore and Watson, 1989). The tail clearly interacts both with the
2,3-BPGA substrate and the phosphatase activator 2-phosphoglycollate (through
charge interactions between the negatively charged phospho groups of the ligands
and the positively charged lysines of the tail), but this first interaction is not essential
for enzyme activity. Further studies on the interaction of the tail with active
site-bound ligands, and differences between S. pombe and S. cerevisiae mutases are






The crystal structure of S.cerevisiae PGAM shows that the cleft containing
the active site is rich in basic residues. Analysis of the enzyme's electrostatic field
shows that it is consistent with a role for these residues in the long range attraction of
substrates (Warwicker, 1986. The recent 2.3A strucuture shows that this effect is
even greater than the original analysis of the 2.8 A structure suggested (Rigden et al.,
1997). Figure 5.1 shows the solvent-accessible surface highlighting positive and
negative electroststic potentials. The concentration of basic residues in the active site
cleft is very clear. As would be expected, the enzyme has been shown to be inhibited
by a wide range of anionic compounds (Rose, 1980), with K, values in the
micromolar to millimolar range. Among the best inhibitors found were benzene
carboxylates and inositol hexakisphosphate.
Some of these compounds have recently been modelled into an unligated
structure of S. cerevisiae PGAM (Rigden, D.J., unpublished results). The coordinates
used for the modelling of the ligand-enzyme complexes were those of Littlechild, J.
A., Campbell, J., Rawas, A. & Watson, H. C. (unpublished data). This structure is of
2.0A resolution and shows some differences at or near the active site, probably due to
the absence of the sulphate groups which are bound in the active site of the 2.8A
structure. The implied flexibility was taken into account during the refinement
procedure. When this work was being carried out, the 2.3A structure (Rigden et al.,
1997) had not been determined. The compounds modelled were inositol hexakis¬
phosphate (IHP), benzene hexaphosphate (BHC), benzene-1,2,4,5-tetraphosphate
(B1245), benzene-1,2,'4-triphosphate (B124), benzene- 1,2,3-triphosphate (B123) and
benzene-1,2,4-triphosphate (B124). Favourable structures were found with each of
the molecules binding in the active site. Figures 5.2-5.7 show the positions of these
molecules in the active site, and possible interactions between the ligands and active
site residues. As would be expected, the ligands with a higher number of negatively
charged phospho groups look likely to form more hydrogen bonds with the enzyme,
and therefore would be expected to have lower Kj values. With the three benzene
triphosphates, the different positions of the phospho groups on the molecule mean
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Figure 5.1
The solvent-accessible surface of a PGAM subunit with the positive and negative
electrostatic potential coloured red and blue respectively. The catalytic site cleft is in
the centre of the figure, and the concntration of basic residues is clear. The active site
histidines are located in the upper left area of the electrostatically positive area. The







A MOLSCRIPT diagram showing inositol hexakisphosphate (IHP) modelled in to
the active site of S.cerevisiae PGAM. Residues which are not thought to hydrogen
bond to IHP have been omitted.
IHP was placed in the active site using manual positioning obtained using the
program GRID.
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O*~Hydrogen bond and its length If;- Corresponding atoms involved in hydrophobic contacts)
Figure 5.3
A LIGPLOT diagram of benzene hexacarboxylate (BHC) modelled in to the active
site of S.cerevisiae PGAM, showing possible interactions between the ligand and
active site residues.
The benzene carboxylates were placed using the program LIGIN, and the positions
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{f}- Hydrogen bond and its length
Non-ligand residues involved in hydrophobic
contacts)
Corresponding atoms involved in hydrophobic contacts)
Figure 5.4
Benzene 1,2,4,5-tetracarboxylate (B1245) modelled in to the active site of







0 0 Non-ligand bond
£)-3io--0 Hydrogen bond and its length
Arg 7
His S3 Non-ligand residues involved in hydrophobic
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Figure 5.5
Benzene 1,2,4-carboxylate (B124) modelled in to the active site of S.cerevisiae








■Q 0 Non-ligand bond
■Q>- Hydrogen bond and its length. Corresponding atoms involved in hydrophobic contacts)
Hs S3 Non-ligand residues involved in hydrophobic
contacts)
Figure 5.6
Benzene 1,2,3-tricarboxylate (B123) modelled in to the active site of S.cerevisiae
PGAM, showing possible interactions between the ligand and active site residues.
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O # Ligand bond 55553
<f) 0 Non-ligand bond
Q-Hydrogen bond and its length
Non-ligand residues involved in hydrophobic
contacts)
Corresponding atoms involved in hydrophobic contains)
Figure 5.7
Benzene 1,3,5-tricarboxylate (B135) modelled in to the active site of S.cerevisiae
PGAM, showing possible interactions between the ligand and active site residues.
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that different interactions are formed, and we would therefore expect to see
differences between the K, values of these inhibitors. The determination of the K,
values could provide support for the models of inhibitor binding.
It has previously been described how exposure to thermolysin causes a
decrease in the S. cerevisiae mutase activity (Section 3.2). 60% of the activity is lost
in the first twenty minutes of proteolysis, during which time a portion of the tail is
removed. Further loss of activity is attributed to more extensive digestion affecting
other parts of the enzyme. However, the presence of the substrate 2,3-BPGA
provides some protection against limited proteolysis by thermolysin (Section 3.5),
which suggests that the tail is interacting with the ligand bound in the active site.
3-PGA does not provide this protection and it was therefore concluded that the
presence of at least two phospho groups was necessary to draw the tail into the active
site. Benzene hexacarboxylate (BHC) and IHP carry multiple negative charges and
therefore could be expected to provide protection against proteolysis if they also bind
in a suitable position in the active site. However, the benzene carboxylates are likely
to bind deeper in the catalytic pocket than IHP and therefore would be less
accessible, and so there may be a difference in the degree of protection afforded by
the different inhibitors. The proposed positions of IHP and BHC relative to the
pocket mouth are shown in figure 5.8.
The role of the tail in binding these ligands can be further studied using the
mutase from S. pombe. This enzyme does not have a tail, and the kcat of this enzyme
is around one-fifth that of the S. cerevisiae mutase (Nairn el al. 1994). We would
therefore expect the effects of treatment with thermolysin to be different. As there is
no tail to lose, we would not expect to see the first sharp loss of activity. There may
however be a more gradual loss, with the protein being digested in the same way that
the S. cerevisiae mutase is further digested on prolonged exposure to the protease. If,
as thought, protection against proteolysis is afforded by the bisphosphoglycerate as a
result of the negative charges drawing the tail into the active site, there should be no
such protection with the S. pombe mutase. If the tail is involved in ligand binding, we




A MOLSCRIPT diagram comparing the most favoured position of IHP (in white)
and BHC (in black).
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A sample of recombinant S. pombe PGAM (Nairn et al. 1996) was available
in a partially purified form (a gift from Dr. J. Nairn) and was purified to homogeneity
as described in Section 2.2.6. The kinetic constants and KM values for each of the
substrates were determined as a basis for further study of the effects of the inhibitors.
5.2 Phosphoglycerate mutase from Schizosaccharomyces pombe
5.2.1 Preparation ofpure enzyme
Recombinant S.pombe PGAM was obtained partially purified (after
ammonium sulphate fractionation and ion exchange chromatography). It was purified
to homogeneity (as indicated by a single band on a Coomassie-stained SDS-PAGE
gel) using a single gel filtration step, identical to the final step in the purification of
the S.cerevisiae enzyme.
5.2.2 S.pombe phosphoglycerate mutase kinetics
The kinetic properties of S.pombe PGAM were determined in the same way
as for the S.cerevisiae enzyme. The Hanes primary plot shows the shape characteric
of a ping pong mechanism, with the lines intersecting at the y axis (See figure 5.9).
The secondary plot gives the kinetic constants.
The Km values for the substrates are very similar to those for the wild type
S.cerevisiae enzyme (KM3PGA - 560pM, KM2,3BPGA - 3.2pM). The Vmax is approximately
one quarter that of S.cerevisiae PGAM.
Km3PGA - 580pM
- 4.6pM





Hanes plots showing kinetic data obtained for S.pombe PGAM. The pattern seen in
the primary plot corresponds to a ping-pong mechanism. The inset graph is the
secondary plot required for calculating the kinetic constants. Assays carried out as
described in section 2.2.8.
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5.3 The effect of inhibitors on coupling enzymes
The mutase activity of PGAM is measured using the coupled assay system
described in section 2.2.8. There is a possibility that the inhibitors tested also have an
affinity for the coupling enzymes enolase, pyruvate kinase and lactate
dehydrogenase, and therefore the coupled assay may not give an accurate measure of
the effect on mutase activity only. Coupling enzymes are added in excess to ensure
that the overall measured rate is that of the first reaction only. In the mutase assay,
the product (2-PGA) is converted to lactate (via PEP and pyruvate) as soon as it is
formed, with the concomitant measurable oxidation ofNADH.
PGAM is routinely added to the assay in dilutions which give a change in A340 of
0.02/min or less, which is equivalent to 0.0032pmol of 2-PGA produced/min. An
excss of enolase (0.08 units) is added to the assay mix, allowing the turnover of
0.08pmol of 2-PGA/min. The potential turnover of enolase is therefore 25x that of
the maximum allowed mutase turnover.
Pyruvate kinase and lactate dehydrogenase (0.5 units each) are added,
allowing a turnover 6x that of the enolase and 150x that of the mutase. As the
coupling enzymes are present in such excess, it should be possible to retain sufficient
activity to immediately convert the mutase product, even if the inhibitors do have
significant affinity for the coupling enzymes.
This was tested by adding low concentrations of 2-PGA to the standard assay
mix (without the mutase substrates, 3-PGA and 2,3-BPGA, and PGAM) in the
presence and absence of the highest concentration of inhibitor assayed. This was
done for each inhibitor studied at different 2-PGA concentrations. At very low
concentrations (<2p,M) no inhibition was observed. At 5p.M 2-PGA (greater than the
maximum possible product concentration), a small degree of inhibition (<20%) was
observed. This was eliminated when the amount of coupling enzymes in the assay
was doubled. It was decided to use this increased enzyme concentration in the
inhibitor assays to ensure that any inhibitory effects on the coupling enzymes were
insufficient to affect the measured mutase rate. When this increased amount of
coupling enzymes was itself doubled, no increase in rate was observed.
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5.4 The inhibition of S.cerevisiae and S.pombe phosphoglycerate
mutase activities
Each of the inhibitors was tested with the S. cerevisiae and S.pombe PGAM,
and the results represented on a combination plot (Chan, 1995). The results are
shown in figures 5.10-5.13. Each inhibitor gave a horizontal line, indicating that the
inhibition was competitive in nature. The value of Kj was given by the reciprocal of
the vertical intercept. As the line is horizontal, it is difficult to gauge the goodness of
fit, and changing the scale of the vertical axis can give a very different picture. In
order to obtain a fair indication of the standard error associated with the value
obtained for Kf, the reciprocal of each of the values plotted on the vertical axis was
taken. For a perfect straight horizontal line, these values would be equal, and equal to
Kj. The standard error for these data was calculated and is given after each value.
In theory, each individual substrate concentration should give the same value
for the vertical axis function for any inhibitor concentration. It can be seen from the
graphs that there is variation, with points appearing above and below the line of best
fit. If higher inhibitor concentrations consistently gave points above the line and
lower concentrations points below the line (or vice versa), this could indicate a
systematic error in the experiment. However, inspection of the data shows that the
distribution of points around the line of best fit is random.
The K; values determined using the combination plots are given below.
Kj (pM)
S. cerevisiae S.pombe
IHP 4+1.0 35 + 5.5
BHC 6 + 0.6 22 + 2.4
B1245 12+1.0 55 + 3.5
B124 21+2.8 62 + 5.0
B123 23 + 1.8 67 + 2.2
B135 24 + 3.6 53 + 3.2
Table 5.1







Combination plots (Chan, 1995) showing inhibition of S.cerevisiae PGAM by IHP,
B1245 and B123. Standard kinetic parameters are used, with [I] (concentration of
inhibitor), v0(rate of reaction at a particular substrate concentration in the absence of
inhibitor) and V; (rate of reaction at a particular substrate concentration in the










































Combination plots (Chan, 1995) showing inhibition of S.pombe PGAM by BHC,
B124 and B135.
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With the S.cerevisiae enzyme, the tightness of binding of the inhibitors increases
with the number of negatively charged groups. Although IHP and BHC are thought
to bind in different positions, their K; values are very similar. There are no significant
differences between the K, values for the benzene tricarboxylates. This is unexpected,
as the modelling suggests that the different positions of the negatively charged
groups could lead to different interactions and different numbers of interactions being
formed (see figures 5.5-5.7), and it was expected that this would be reflected in the
binding efficiency.
Differences are seen with the S.pombe enzyme which would suggest
differences between the two active sites and the interactions formed between active
site residues and the inhibitors. The K| values are significantly higher than for the S.
cerevisiae mutase. This could be due to the absence of a tail, if it is indeed involved
in binding the inhibitors. However, if this were the case, we might also expect the KM
values for the substrates to be higher, and they are very similar. Another possibility is
that there are differences in the active site that do not significantly affect the binding
of the substrates, but do affect the binding of the more negatively charged inhibitors.
Two of the residues thought to be involved in the binding of at least three of the
inhibitors (B1245, B124, B123) are Val23 and Val25. In the S. pombe PGAM, these
residues are a lysine and a proline respectively. The presence of a proline in
particular could alter the active site so that the interactions formed with the 5".
cerevisiae enzyme are not possible with that from S. pombe. The K| for B135 is lower
than that for the other tricarboxylates, and is similar to that for B1245. Looking at the
modelled complexes in Figures 5.4 and 5.7, it is clear that B135 would be likely to
form fewer interactions in the S.cerevisiae active site than the other inhibitors, but
B124 and B123 are thought to interact with the valines that are substituted in the S.
pombe mutase and this could explain the differences between the two enzymes.
The differences between the S. pombe and the S. cerevisiae enzyme affect the
affinity for IHP more than BHC. The Kj values for these two inhibitors are very
similar with the S. cerevisiae mutase (4pM and 6pM respectively), but differ quite
significantly with S. pombe (35pM and 22pM). This may be as a result of a greater
interaction of the tail with IHP (see next section), or due to differences in the active
115
sites. There are two replacements in the vicinity of the proposed IHP binding site.
Asn204 in the S. cerevisiae enzyme is replaced with a glutamate, and Glul5 is
replaced with a lysine. The first change would be expected to reduce the binding
efficiency of an anionic molecule, whereas the second would increase affinity.
However, BHC is thought to bind near to Glul5 and distant from Asn204, so the
overall effect would be different for each molecule, and could give rise to the
differences seen in the K, values.
5.5 Ligand protection against proteolysis
Figure 5.14 shows the effects of thermolysin digestion on S.cerevisiae PGAM
incubated with saturating (50pM) and non-saturating (5pM) concentrations of BHC.
Saturating BHC afforded a similar degree of protection in the initial phase of
proteolysis to that provided by 2,3-BPGA, non-saturating rather less. However, the
first part of the graph is less steep and as this is the part that is thought to correspond
to the removal of the tail, this would suggest at least some protection against its
removal.
Figure 5.15 shows the results for saturating and non-saturating IHP, whch
appears much more effective than the BHC or 2,3-BPGA. At saturating
concentrations (50pM), removal of the tail appeared to be completely stopped,
leaving only the slower process involving other parts of the protein. Again, the lower
concentration (5pM) was less effective. This is consistent with the idea that
inhibition and protection are due to binding at a particular site. These results tie in
with the modelling, which shows that BHC binds deeper in the catalytic pocket than
IP6. Therefore IP6 would be expected to interact more readily with the tail than BHC
and so provide a greater degree of protection.
As detailed in Section 3.2, the loss of activity due to limited proteolysis by
thermolysin can be divided into two phases. There is an initial rapid loss of activity
due to the removal of a portion of the tail, followed by a gradual decrease due to
more extensive proteolytic attacks. As the PGAM from S.pombe does not possess a




Graph showing the loss of activity of S. cerevisiae PGAM due to limited proteolysis
by thermolysin in the presence and absence of BHC and 2,3-BPGA.
100pg/ml PGAM was incubated with 10pg/ml thermolysin and ligands at 20°C. The
concentrations of ligands are given in the key. At the times indicated, samples were
removed and EDTA added to lOmM to inactivate the thermolysin. Mutase actvity
was determined as described in Section 2.2.8
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Figure 5.16 compares the effect of thermolysin on the mutase activity of the PGAMs
from S. pombe and S. cerevisiae in the presence and absence of the substrate
2,3-BPGA. Comparing the two unligated enzymes, the S. pombe mutase activity is
much less affected than that of the S. cerevisiae mutase, only losing 35% of activity
in two hours compared with over 80%. The main difference is in the initial stages,
which is believed to correspond to the loss of a portion of the tail, which is of course
absent in the S. pombe mutase. The more extensive proteolysis seen in the later
stages of incubation of S. cerevisiae mutase with thermolysin probably also occurs
with the S. pombe enzyme and is responsible for the gradual loss of activity
observed. The addition of 2,3-BPGA provides a considerable degree of protection
against proteolysis for the S. cerevisiae enzyme, but has very little effect on the
inactivation of S. pombe PGAM. This again provides evidence that the protection
afforded by the ligand is due to interaction with the tail region.
Figure 5.17 compares the results of incubating S. pombe and S. cerevisiae
mutases with thermolysin and the inhibitors IHP and BHC. It shows that in the
presence of saturating IHP, the degree of inactivation is very similar to that of S.
pombe mutase in the presence or absence of ligands. This concentration of IHP
therefore appears to completely protect the tail from removal by thermolysin.
5.6 Discussion
The biochemical data provide support for the modelling of these polyanionic
inhibitors in the catalytic site of S. cerevisiae PGAM. The K; values and the degree
of protection afforded against digestion by thermolysin are consistent with the
proposed binding sites. The tail of the enzyme clearly interacts with IHP and is
thought to be drawn over the active site. It was hoped that the inclusion of this ligand
in the mother liquor during crystallization would lead to a conformation of the
enzyme with a structured tail. This was attempted during the recent crystallization of
S. cerevisiae PGAM, but no trace of the inhibitor was found in the resulting structure
(Rigden et al. 1997). The final determination of the binding sites of these compounds
must await further X-ray crystallographic studies (or nuclear magnetic resonance
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Time (rrin)
+ 5uM IHP * 50uM HP
B 0.5mM BPGA v no ligands
Figure 5.16
Comparison of the effects on limited proteolysis on PGAM from S. cerevisiae and S.
pombe in the presence and absence of 2,3-BPGA.
lOOpg/ml PGAM was incubated with 10pg/ml thermolysin and ligands at 20°C. The
concentrations of ligands are given in the legend. At the times indicated, samples
were removed and EDTA added to lOmM to inactivate the thermolysin. Mutase
actvity was determined as described in Section 2.2.8.
S.p. - S. pombe PGAM
S.c. - S. cerevisiae PGAM
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Time (min)
*S.c. 50uM IHP ±S.c. 50uM BHC
¥S.p. 250uM IHP BS.p. 250uM BHC
Figure 5.17
Comparison of the effects of BHC and IHP on the limited proteolysis of PGAM from
S. cerevisiae and S. pombe.
lOOjag/ml PGAM was incubated with lOpg/ml thermolysin and ligands at 20°C. The
concentrations of ligands are given in the legend. At the times indicated, samples
were removed and EDTA added to lOmM to inactivate the thermolysin. Mutase
actvity was determined as described in Section 2.2.8.
S.p. - S. pombe PGAM
S.c. - S. cerevisiae PGAM
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studies for the smaller S. pombe PGAM), especially in light of the revised structure
recently determined.
The results obtained from the limited proteolysis experiments provide
additional support for the work described in chapters three and four. It was shown in
chapter three that the initial rapid inactivation of S. cerevisiae PGAM incubated with
thermolysin was due to the loss of a portion of the flexible tail region, and the
addition of 2,3-BPGA provides protection against this inactivation. It was shown in
chapter four that a mutant with the two C-terminal lysines replaced with uncharged
alanines is not protected against proteolysis by 2,3-BPGA, suggesting that these
positively charged lysines interact with the negatively charged groups, drawing the
tail over the active site. As would be expected, the highly charged inhibitor
molecules also appear to interact with the tail, and also provide protection against
proteolysis. The modelling suggests that IHP and BHC bind in different positions,
with IHP nearer the mouth of the catalytic pocket, and this is supported by the
observation that IHP provides a greater degree of protection. The S. pombe enzyme
does not have a tail, and the pattern of inactivation and the lack of protection by
2,3-BPGA are consistent with the role of the tail as described.
As described in section 1.13 and chapter 6, the cofactor-dependent
monophosphoglycerate mutases such as those from S. cerevisiae and S. pombe are
closely related to the bisphosphoglycerate mutases found in mammalian erythrocytes,
with sequence identities in the 40-50% range (see table 1.2). BPGAM is of
pharmacological interest as it controls the concentration of 2,3-BPGA in erythrocytes
and so influences the affinity of haemoglobin for oxygen. Therefore the results







The differences between the mono- and bisphosphoglycerate mutases have
been described in Section 1.11. One of the key differences in the amino acid
sequences of the phosphoglycerate mutases is at residue 11 (using S. cerevisiae
numbering). This is a serine in all the monophosphoglycerate mutases for which
sequences have been determined, but a glycine in bisphosphoglycerate mutases (see
Figure 1.4). It has been suggested that this serine residue provides a phospho ligand
for the binding of the 2,3-BPGA substrate to the active site of the S. cerevisiae
enzyme (Fothergill-Gilmore and Watson, 1989). This residue would interact with the
phospho group that is transferred to His8. Clearly, the presence of a glycine in this
position would reduce the number of phospho ligands available, and facilitate the
release of this molecule once formed in the active site of the bisphosphoglycerate
mutase, which primarily catalyzes the 2,3-BPGA synthase activity.
Another residue that differs between the mono- and bisphosphoglycerate
mutases is residue 60, conserved as an alanine in monophosphoglycerate mutases and
as a serine in bisphosphoglycerate mutases. This residue is in the active site, but has
not been specifically implicated in ligand binding. Part of the 2.8A structure
(Watson, 1982) showing the positions of key active site residues (including Serll
and Ala60) are shown in Figure 6.1. On the left side of the diagram (under the
heading PGAM) are the residues found in the S. cerevisiae enzyme. BPGAM simply
has Serl 1 to Gly and Ala60 to Ser substitutions. Also shown are the sulphates which
were present in the active site, and were thought to bind in the same position as the
phospho groups on the 2,3-BPGA substrate. The functional group of Serl 1 is clearly
directed into the active site, and is close to one of the bound sulphates. This is the
sulphate binding near His8, which would represent the phospho group that is
transferred to this residue to form the phospho enzyme. When Ala60 is replaced by a
serine, the functional group is nearer to the second sulphate.
A mutant in which Serl 1 was replaced with glycine was shown to have considerably
reduced mutase activity, but was extremely unstable (White, 1989). It was hoped that




The active site of phosphoglycerate mutase from S. cerevisiae showing residues
thought to be involved in the mutase/synthase relationship. Also shown are the
sulphates which were bound in the active site when the enzyme was crystallized, and
which are presumed to bind in the positions occupied by the phospho groups of
2,3-BPGA when this is bound to the enzyme (Winn et al., 1981).
BPGAM
This shows the same structure, and simply replaces Serl 1 and Ala60 with alanine
and serine respectively. These are substitutions suggested by the alignment of the
amino acid sequences of mono- and bisphosphoglycerate mutases.
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mutants designed to study the role of Serl 1 and Ala60 were available - S11A, A60S
and the double mutant S11A/A60S. These were constructed by Dr. Malcolm White
using the mutagenesis and expression system described previously (Section 1.14,
White and Fothergill-Gilmore, 1992).
6.2 Expression of mutants
All the mutants grew on YEPD using glucose as a carbon source and so show
some mutase activity. The yeast was lysed using glass beads after overnight growth
(as described in Section 2.2.4) and the lysate electrophoresed in an SDS-PAGE gel
(see figure 6.2). All the mutants are overexpressed to about the same level as the wild
type enzyme, around 20-30% of total cell protein (as estimated using SDS-PAGE).
6.3 Growth of mutants
The growth characteristics of the mutants in YEPD were investigated and
growth curves are shown in figure 6.3. A60S gives a curve similar in shape to the
wild type, but where Ser-11 is replaced with Ala (S11A and SI 1A/A60S), there is a
noticeably slower doubling time in logarithmic phase, so these mutants reach
stationary phase later than the wild type and A60S mutant, although they do
ultimately reach the same cell density in stationary phase.
6.4 Purification of SUA and A60S
The A60S mutant was purified in the same way as the wild type enzyme, as
described in section 2.2.6. The S11A mutant did not bind to the QA52-cellulose ion
exchange column under the conditions used in the standard purification procedure
(lOmM Tris.HCl pH8.0, 4°C). The SUA was collected in the buffer wash and
purified to homogeneity on the Superose 12 column.
The behaviour of the S11A mutant on the Superose 12 column was also
different to the other PGAMs studied. The wild type and other mutants all elute from




Cell lysates from overnight cultures lysed with glass beads and electrophoresed in a
12% SDS-PAGE gel as described in Section 2.2.3.
1. S150-2B GPM::HIS3 + pVT-gpm
2. S150-2B GPM::HIS3 + pVT-A60S
3. S150-2B GPM::HIS3 + pVT-Sl 1A
4. S150-2B GPM::HIS3 + pVT-Sl 1A/A60S
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time (hours)
*WT VA60S bS11A aS11A/A60S
Figure 6.3
Growth curves for S150-2B GPM::HIS3 expressing wild type or mutant PGAM.
An overnight culture of each was used to innoculate 500ml YEPD (section 2.2.2.1) to
0.1 OD600. This was then incubated (with shaking) at 30°C, and small samples taken
at intervals to determine optical density. Each point represents the mean value
obtained from three cultures.
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Figure 6.4
Elution profiles of wild type PGAM and S11A from a Superose HR12 gel filtration
column. Flow rate 0.3ml/min, chart speed 0.5cm/ml.
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Superose 12 is a size exclusion column, this would imply a change in the size or
shape of the molecule. This change could be due either to a change in the size of the
subunit or a change in the oligomeric structure. It can be seen from the SDS-PAGE
of the crude lysates (Figure 6.2) that there is no significant change in the subunit size.
In order to investigate the oligomeric structure, samples of wild type and
SUA protein (in the presence and absence of 2,3-BPGA) were cross-linked using
glutaraldehyde (see section 2.2.11) and run on a 9% SDS-PAGE gel (figure 6.5).
This gel shows clearly that the SI 1A exists in a tetrameric form like the wild type
under these conditions. However, the size of the SI 1A tetramer appears to be slightly
smaller than the wild type tetramer, and this could explain the retardation on the size
exclusion column. No change is seen when the enzyme is incubated with the
substrate 2,3-BPGA (0.5mM) before cross-linking. The enzyme is still in tetrameric
form.
6.5 Specific activities of S11A and A60S
The mutase, synthase and phosphatase activities were measured as described
in section 2.2.8, and are shown in the table below.
mutase synthase phosphatase fold increase
with 2-PG
WT 970 0.01 0.02 18
a60s 620 0.01 0.02 3.1
sua 40 nd nd nd
Table 6.1
The specific activities of S11A and A60S PGAM. Activities are expressed as pmol
NAD'produced/min/mg PGAM.




SDS-PAGE showing the results of cross-linking wild-type PGAM and S11A. Theposition of the tetramer is marked.
1. Wild type PGAM
2. Wild type PGAM incubated with 0.5mM 2,3-BPGA3. S11A
4. SI 1A incubated with 0.5mM 2,3-BPGA
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6.6 Kinetic data for A60S and SUA
The kinetic parameters of the mutase reaction (KM3PGA, KMBPGA and kcat) were
measured. Figure 6.6 shows Hanes plots for each and these show the characteristic
pattern expected for a Ping-Pong mechanism. The table below shows the kinetic data
derived from these graphs.
KM3PGA pM Kmbpga pM kcat S"1
WT 470 3.2 530
A60S 430 7.2 370
SUA 710 30 20
Table 6.2
Kinetic constants for SI 1A and A60S.
The kinetic parameters for A60S are similar to those for the wild type. The KM for
3-PGA is slightly lower, the KM for 2,3-BPGA is aproximately doubled, and the kcatis
slightly decreased. S11A shows more significant differences to the wild type. Both
Km values are increased - for 3-PGA only slightly, but for 2,3-BPGA the difference is
10-fold. The kcat is reduced 25-fold.
6.7 Stability of S11A
Mutant S11A is considerably more labile than the wild type enzyme. Wild
type PGAM is stable for at least five days in 50mM Tris.HCl pH8.0 at 4°C (see
figure 6.7). For longer term storage, the enzyme is kept in 80% saturated ammonium
sulphate at 4°C. Under these conditions it is stable for at least one month. S11A loses
activity rapidly under the same conditions. After 5 days at 4°C, 80% of activity is
lost, and a doublet is seen on an SDS gel, indicating that some degree of degradation
has occurred (figure not shown). In 80% saturated ammonium sulphate, S11A is
stable for around 14 days at 4°C, and activity decreases slowly after this. The
fractions exhibiting mutase activity that eluted from the QA52-cellulose column were






Hanes plots showing kinetic data obtained for A60S (A) and SUA (B). The patternseen in the primary plots correspond to a ping-pong mechanism. The inset graphs arethe secondary plots required for calculating the kinetic constants. Assays carried out
as described in section 2.2.8.
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Figure 6.7
Graph showing the stability of wild type PGAM and S11A over time.
Storage conditions: 50mM Tris-HCl pH 8.0, 4°C.
Mutase activity was measured as described in Section 2.2.8, and expressed as a
percentage of initial actvity, ie-activity immediately following purification on Day 0.
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taken from this stock and further purified on the Superose gel filtration column as
required for kinetic analysis.
6.8 Circular dichroism spectra.
The far uv spectra of the wild type and A60S and S11A mutants are shown in
figure 6.8, and their near uv spectra in figure 6.9. There are some significant
differences, particularly in the spectra of SI 1 A, which imply that both the secondary
and tertiary structures of this mutant differ from the wild type. This ties in with the
results from the gel filtration column.
It has been demonstrated previously that the addition of 2,3BPGA to the wild
type enzyme (which would lead to the phosphorylation of His 8 in the active site)
does not have any effect on the far and near uv spectra, and therefore does not
significantly affect the structure of the enzyme (White et al. 1993). Figures 6.10, 6.11
and 6.12 are the far uv spectra of wild type PGAM, A60S and S11A respectively,
alone and incubated with 0.5mM BPGA (the concentration used in the standard
mutase and phosphatase actvity assays). The spectra for both the mutants change
when the BPGA is added, suggesting that the phosphorylation of the enzymes leads
to a change in secondary structure. No such change was observed for the wild type
enzyme.
6.9 The S11A/A60S mutant
6.9.1 Purification ofSI1A/A60S
This mutant was very unstable, and could not be purified to homogeneity
using the methods previously described. After the overnight dialysis following the
ammonium sulphate fractionation step, there was a considerable amount of
precipitation in the dialysis tube. On testing the remaining soluble contents of the
tube, it was found that 50% of the total protein content and 100% of mutase activity
had been lost. It seems clear that the mutant enzyme denatures during the dialysis and
comes out of the solution. The addition of glycerol (25% v/v) to the dialysis buffer
135
Figure 6.8
Far uv cd spectra of wild type PGAM, A60S and S11A.
Key to colours: Green - wild type PGAM, brown - A60S, blue -S11A.
Protein concentrations and path lengths: WT - 0.36mg/ml, 0.02cm, A60S -




Near uv cd spectra of wild type PGAM, A60S and S11A.
Key to colours: Green - wild type PGAM, black - A60S, blue -S11A.
Protein concentrations and path lengths: WT - 0.36mg/ml, 0.5cm, A60S - 0.47mg/ml,













Far uv cd spectrum of wild type PGAM incubated for five minutes with 0.5mM
2,3-BPGA. Protein concentration - 0.36mg/ml, path length - 0.02cm.




Far uv cd spectrum of A60S incubated for five minutes with 0.5mM 2,3-BPGA.
Protein concentration - 0.47mg/ml, path length - 0.02cm.




Far uv cd spectrum of S11A incubated for five minutes with 0.5mM 2,3-BPGA.
Protein concentration - 0.59 mg/ml, path length - 0.02cm.
Key to colours: Blue - without 2,3-BPGA, orange - with 2,3-BPGA
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did not stop this denaturation. Shorter dialysis times were also tried, but the enzyme
was found to denature within four hours. Polyethyleneimine (PEI) has been used to
remove cell debris, lipids and nucleic acid from lysates of S. cerevisiae (Millburn et
ah, 1990). The lysate must first be clarified, either centrifugally or by the
addition of borax. Addition of PEI at low concentrations (0.075% v/v) followed by
centrifugation to remove the flocculated material gives a supernatant that is almost
free of DNA, RNA and lipids. Millburn et al. also found that up to 30% of protein is
removed, although the two soluble enzymes monitored in their trials were unaffected.
Using PEI flocculation as the first stage in purification would remove the need for
prolonged dialysis as the supernatant could be loaded directly onto the
QA52-cellulose column. In the work described, 1.5% NaCl was added, although it
was noted that this was probably not necessary due to the concentration of salt
present in yeast homogenates. This could of course be a problem if the supernatant
was loaded directly onto the ion exchange column, as it may affect the binding of the
proteins to the matrix. However, the S11A mutant does not bind the matrix, and so
we would not expect the double mutant to bind. The problem would be increased
contamination from other proteins not binding.
The yeast expressing the double mutant was grown and lysed in the usual
way, although the lysis buffer used was 30mM Tris-HCl pH8.0 containing 25%
glycerol. The lysate was clarified by centrifugation (20 minutes, 2000g). An equal
volume of 0.2% polyethyleneimine and 25% glycerol (pH adjusted to 8.0) was added
and the mixture stirred for 30 minutes at 4°C. This gave final concentrations of 0.1%
PEI and 15mM Tris-HCl. The flocculant was removed by centrifugation (20 minutes,
2000g), and the supernatant was loaded onto the QA52-cellulose column
(equilibrated with 15mM Tris-HCl, 25% glycerol, pH 8.0 at 4°C), at a flow rate of
O.lml/min. As expected, the protein with associated mutase activity did not bind to
the column under these conditions, however a significant degree of purification is
evident (figure 6.13). From SDS-PAGE, it is estimated that at least 80% of the
protein that does not bind to the ion exchange column is the S11A/A60S mutant.




SDS-PAGE showing the partial purification of SI 1A/A60S.
1. Crude lysate of S150-2B GPM::HIS3 + pVT-SllA/A60S
2. Lysate after treatment with PEI
3.Partially purified S11A/A60S following ion exchange chromatography on the
QA52- cellulose column.
The position of the SI 1AA60S subunit is shown.
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4°C. Therefore it was not possible to further purify the mutant using the Superose 12
column, as the FPLC system operates at room temperature. The partially purified
enzyme was used to give an indication of the level of the three activities exhibited by
this mutant, but it was clear that it was too unstable to give further useful
information.
6.9.2 Activities ofSI1A/A60S.
The mutase, synthase and phosphatase activities of the partially purified
double mutant were measured as described in section 2.2.8. The protein
concentration was determined using the dye-binding assay of Sedmak and Grossberg
(1977). The generally more accurate spectrophotometric method (Edelhoch et al.,
1957) could not be used due to the presence of contaminating proteins. The specific
activities were calculated, and modified to take into account the other proteins
present which did not contribute to the activities. It was estimated that 80% of
protein present was the S11A/A60S mutant, and so 80% of the measured protein
concentration was used to calculate the modified specific activities. Both are given in
the table below. The activities are expressed as pmol NADH oxidized min"' mg"1, and





The replacement of Ala60 with a serine residue reduced the mutase activity
by approximately one-third, but had no noticeable effect on synthase or phosphatase
activities. This mutation effectively adds another potential phospho ligand to the
active site. Figure 6.1 shows that this would be situated close to one of the sulphates
that is found bound in the active site of the 2.8A structure (Winn et ah, 1981). It is
not in a position that would affect the phospho group bound to His8 in the
phosphoenzyme, but it could be in a position to form an interaction with the phospho
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group of a monophosphoglycerate, or the second phospho group of 2,3-BPGA.
However, the KM values for 3-PGA and 2,3-BPGA are not significantly affected by
the substitution. KM3PGA is very slightly decreased, and KMBPGA is about twice the
value for the wild type. The kcat for the mutase reaction is reduced by about two
thirds. The decreased binding efficiency of 2,3-BPGA could be responsible for the
decreased catalytic efficiency. Alternatively, the 2.8A structure (see section 1.8.2)
shows that there is an intricate web of hydrogen bonds surrounding the two active
site histidines which are likely to be responsible in maintaining these crucial residues
in the correct orientation (Rigden et al., 1997), and the introduction of another group
into the active site may upset this. Part of the active site of this structure is shown in
figure 6.15, showing the revised positions of Serl 1 and Ala60. From the position of
Ala60, the second explanation appears more likely to be correct.
The Serl 1 to alanine mutation has a more profound effect. The KM for
2,3-BPGA in particular is increased 10-fold, and the kcat is reduced 25-fold. The KM
for 3-PGA is less affected, only 1.5-fold higher than that of the wild type enzyme.
These are the results that would be expected due to the position of Serl 1 in the active
site. It is thought to provide a ligand for the phopsho group that is transferred to His8
to form the phospho enzyme, and so would affect the binding of the
bisphosphoglycerate substrate more than the monophosphoglycerates, the phospho
groups of which would be in the other phospho group binding postition (interacting
with the helix dipole, see section 1.9.2). The results obtained with the SUA mutant
are in agreement with the corresponding mutant of human bisphosphoglycerate
mutase, G13S (Garel et al., 1994). This mutant shows an increased mutase activity
and a decreased KM for 2,3-BPGA, while the synthase activity and the KM for 3-PGA
are not significantly altered by the substitution.
The position of Serl 1 also suggests a role in the stabilization of the phospho
enzyme. It has been suggested that the low level of phosphatase activity is due to the
non-productive transfer of the phospho group from the phospho enzyme to water.
This activity is enhanced by the addition of the substrate analogue
2-phosphoglycollate. This is thought to stimulate the phosphatase activity by binding
in the active site and mimicking the monophosphoglycerate substrate which accepts
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the phospho group in the mutase reaction. 2-phosphoglycollate cannot accept the
group, but facilitates its transfer to water. The phosphorylated form of
bisphosphoglycerate mutase is more unstable than that of monophosphoglycerate
mutases (Rose, 1980), which would correspond to the lack of this extra phospho
ligand in the former. The G13S mutant of human red cell bisphosphoglycerate
mutase has a decreased phosphatase activity, which would be the expected result of
adding this phospho ligand. However, in the S11A mutant the phosphatase activity is
completely abolished. The enhanced phosphatase activity in the presence of
2-phosphoglycollate is also absent in this mutant. It is considerably reduced in the
A60S mutant (from 18-fold in the wild type to 3-fold), and so this residue is
implicated in the binding of this acceptor analogue.
It is possible that the differences in activity and binding efficiency between
the wild type and mutant enzymes are not due to a single residue substitution. When
the circular dichroism (cd) spectra of the wild type and mutants are compared (both
near and far uv), it is clear that there are some differences, particularly with S11A,
which correspond to differences in the secondary and tertiary structure of the
proteins. A change in the structure of this mutant is also suggested by its failure to
bind to the ion exchange column. Serll is implicated in the intricate web of
hydrogen bonds that are found around the two active site histidines, and it is possible
that the replacement of this residue leads to the loss of stablizing contacts. It has been
shown in previous site-directed mutagenesis studies that the replacement of one of
the active site histidines (Hisl 81) led to the destabilization of the enzyme (White et
al., 1993). With this mutant (HI81 A), the binding of 2,3-BPGA and subsequent
phosphorylation of the enzyme led to changes in the conformation of the protein, and
dissociation of the tetramer. With S11A, the tetramer remains intact, as shown by the
cross-linking studies described in Section 6.4 (see figure 6.5), but there are changes
to the protein conformation, as shown by cd spectra (figures 6.10-6.12). The
conformation of the wild type enzyme is unaffected by phosphorylation.
These results underline the need for caution in interpreting the results of
site-directed mutagenesis studies. It is very tempting to attribute differences in
activity and binding efficiency to the addition or removal of a functional group from
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the enzyme. It is important however to ensure that this is indeed the only change to
take place when an amino acid substitution is made. Groups that are involved in the
binding of substrates or in some other way involved with the reaction mechanism
may also be involved in structurally important contacts in the native enzyme. If this
is the case, the replacement of these residues may affect the binding of substrates and




The Role of Glu86
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7.1 Introduction
The residue Glu327 is conserved in the cofactor-dependent phosphoglycerate
mutases and the C-terminal phosphatase domain of the bifunctional enzyme
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (Fru-2,6-BPase), see Figures
1.4 and 1.13. Site-directed mutagenesis studies have suggested a role for this residue
in catalysis. One of the key features of the active site of the histidine phosphatase
family of enzymes, which includes the cofactor-dependent phosphoglycerate
mutases, rat prostatic acid phosphatase (RPAP) and Fru-2,6-BPase is a pair of
histidine residues. In the the 2.8 A structure of PGAM from S. cerevisiae (where they
are numbered His8 and Hisl 81, they appeared to adopt a parallel or "clapping hands"
formation, about 4A apart. In the new higher resolution structure (Rigden et al.,
1997), they are no longer parallel, but in a conformation closer to that seen in the
related enzymes RPAP and Fru-2,6-P2ase, which could be related to the different
crystallization conditions.
Only His8 (and the corresponding His residue in other mutases) has been
shown to be phosphorylated (Fothergill and Harkins, 1982, Haggarty and Fothergill,
1980, Han and Rose, 1979, Hass et al., 1980). A role for the second His in phospho
transfer has been proposed by Rose (1980), who suggested that this residue donates a
proton to the leaving group. In the unligated enzyme therefore, Hisl81 would be in
the positively charged, protonated state. The phosphorylation of the Fru-2,6-P2ase
domain of rat liver 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase is thought
to proceed in a similar fashion, with the nucleophilic attack of one active site His
(His258) at the phospho group of the substrate leading to the formation of the
phosphoenzyme, with proton donation from the other His (His392) to the leaving
group. Site-directed mutagenesis studies on this enzyme have suggested a role in
catalysis for another active site residue, Glu327, which is conserved in the
cofactor-dependent phosphoglycerate mutases (Lin et al., 1992).
The replacement of this residue with an alanine or a glutamine reduced the
phosphatase activity to 4% and 2% of the wild type activity respectively. When
aspartate was introduced in place of glutamate, activity was reduced by 20%. The
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rate of formation of the phosphoenzyme intermediate was drastically decreased in
each of the mutants, by a factor of at least 1000. The KM values for the substrate
fructose-2,6-bisphosphate were not significantly affected. These results suggest that
Glu327 plays a crucial role in the catalysis of the phosphatase reaction due to
involvement in the formation of the phosphoenzyme. It is proposed that the
negatively charged carboxylate group of the residue maintains the protonated state of
His392. The small effect on the KM of the substrate implies that the major role of this
residue is in catalysis, and not in the binding of the substrate and/or product. It is also
implicated in the hydrolysis of the phosphoenzyme. The rate constants for the
hydrolysis for Glu to Ala and Glu to Gin mutants are 2.7% and 1.3%, respectively, of
the wild type, while that for the Glu to Asp mutant is 60% of the wild type. Glu327
may act as a base catalyst by forming an OH" ion from a water molecule, which then
breaks down the phosphoenzyme by nucleophilic attack (Lee et al., 1996). The Asp
residue also has a carboxylate group, but this is shorter and is in a different
orientation. It appears that the correct orientation of the carboxylate is more
important in the formation of the phosphoenzyme (i.e. in the protonation of His392)
than its hydrolysis.
This Glu residue is also conserved in the cofactor-dependent PGAMs (in S.
cerevisiae PGAM the corresponding residue is Glu86), and it is possible that it plays
an analogous role in the formation of the phosphoenzyme in the mutase reaction. The
replacement of the glutamate with a glutamine should not significantly affect the
structure of the enzyme, as a glutamate and a glutamine would be expected to occupy
a similar space, and glutamine is able to form hydrogen bonds in a similar manner to
glutamate. Therefore the only change should be the removal of the negatively
charged carboxyl group.
The vector pVT-E86Q was constructed as part of an Honours project by four
students (Eve Laird, Elizabeth Lovejoy, Kim Midwood and Sue Webber) using the
Kunkel method as described in Section 2.2.16. The mutant enzyme has subsequently
been expressed in the gpm-deleted strain of S. cerevisiae, purified to homogeneity
and the kinetic parameters determined.
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7.2 Expression of E86Q
The vector pVT-E86Q was used to transform S150-2B GPM::HIS3 using the
method described in Section 2.2.3. The gpm-deleted strain must be grown using a
non-fermentable carbon source (in this case glycerol and ethanol), as the glycolytic
pathway cannot function due to the absence of PGAM. This does create a difficulty
for transformation, as yeast grows only very slowly in this medium (S150-2B
growing in YEPD, with glucose as the carbon source has a doubling time of around
five hours, whereas the doubling time of S150-2B GPM::EIIS3 growing in YEPGE,
with glycerol and ethanol as carbon sources is around fourteen hours). It therefore
takes a considerable time for the yeast to reach the required optical density. Using
standard methods, no transformants were obtained. The addition of carrier DNA
(sonicated herring sperm DNA) did not improve the yield. A modified version of the
method of Geitz et al. (1992) was found to give an improved transformation
efficiency. This method eliminates the incubation of cells with lithium acetate
solution prior to the addition of DNA, and also involves a considerably extended heat
shock, at 15 minutes rather than the usual two. The transformed cells were then
grown in 3 ml of the non-selective YEPGE overnight, before being plated out and
incubated at 30°C. The usual medium for plating out the cells was YOD ura" (see
Section 2.2.2) which is doubly selective: the absence of uracil selects for the presence
of the URA3 gene on the phagemid, and the use of glucose as a carbon source selects
for the presence of the GPM gene. However, the mutase activity of the E86Q mutant
was expected to be much reduced and may be absent altogether, so half of each
overnight culture was plated out onto YOD ura", and half onto YOGE ura", which still
selects for the phagemid but does not require an active mutase. Colonies appeared
after 14 days on the YOD ura" plates, and after 21 days on the YOGE ura" plates. This
shows that at least some mutase activity is retained by the E86Q mutant. SDS-PAGE
shows that, similar to the other mutants, E86Q is expressed at a high level, and
constitutes around 30% of the total cell protein (see Figure 7.1).
The growth curves for wild type and E86Q PGAM in YEPD are shown in
Figure 7.2. The logarithmic phase of growth is considerably slower in the mutant,
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Figure 7.1
SDS-PAGE showing the purification of E86Q. The position of the PGAM subunit isindicated.
Lane 1 Crude cell lysate





Growth curves for S150-2B GPM::HIS3 expressing wild type or E86Q PGAM.
An overnight culture of each was used to innoculate 500ml YEPD (section 2.2.2.1) to
0.1 OD600. This was then incubated (with shaking) at 30°C, and small samples taken
at intervals to determine optical density. Each point represents the mean value
obtained from three cultures.
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which has a doubling time of about ten hours. The mutase activity present in a crude
lysate of S150-2B (the parental strain expressing the single chromosomal copy of the
GPM gene) is about 10 EU/mg (where one EU is defined as lprnol NADH oxidized
/min/mg of protein). This is increased to around 350 EU/mg with S150-2B
GPM::HIS3 transformed with pVT-gpm and expressing the wild type mutase.
However, the cells expressing the E86Q mutant show a mutase activity of less than 2
EU/mg. This is only one-fifth of the activity found in "normal" cells, i.e. those
expressing a single gene copy, and could lead to a decrease in glycolytic flux, with a
build up of metabolites at phosphoglycerate mutase, and therefore a decreased
growth rate.
7.3 Purification of E86Q
The E86Q mutant was purified to homogeneity using the method described in
Section 2.2.5, and no modifications to the standard procedure were required. The
mutant protein displayed similar behaviour to the wild type enzyme on the
QA52-cellulose ion exchange column, and eluted in the same fraction from the
Superose 12 size exclusion column. This mutation is therefore unlikely to have
caused the same disruption to the structure as the replacement of another active site
residue, Serl 1 (Chapter Six). The SDS-PAGE characterization of fractions from the
purification of E86Q is shown in Figure 7.1.
7.4 Specific Activities
The mutase, synthase and phosphatase activities of the E86Q mutant PGAM
were assayed as described in Section 2.2.8. The results are shown in the table below,










Specific activities of wild type and E86Q PGAM. All values are determined from
three different experiments and given as means with less than 5% standard error.
Results are expressed as enzyme units (EU), where one EU represents 1 pmol NADH
oxidized / min / mg of enzyme, and nd means not detectable under the assay
conditions.
7.5 Kinetic Data
The Km values for 3-PGA and 2,3-BPGA in the mutase reaction were
determined for the mutant. The Hanes plot is shown in Figures 7.3. It shows
ping-pong kinetics as described for the wild type. The kinetic data are shown in the
table below, with those of the wild type enzyme for comparison.
Km3PGA (pM) Kmbpga (pM) kcat (s-1)
E86Q 1,110 8.1 4.7
WT 470 3.2 530
Table 7.2
The kinetic constants for wild type and E86Q PGAM.
7.6 Discussion
The results obtained with the E86Q mutant are consistent with a role for this
residue analogous to that suggested for the corresponding residue in the
bisphosphatase domain of the bifunctional enzyme 6-phosphofructo-2-kinase/











Hanes plot showing kinetic data obtained for E86Q PGAM. The pattern seen in the
primary plot corresponds to a ping-pong mechanism. The inset graph is the
secondary plot required for calculating the kinetic constants. Assays carried out as
described in section 2.2.9.
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considerably reduced (over 150-fold), and the phosphatase activity is abolished. The
binding of the substrates, reflected in the KM values, is considerably less affected than
the turnover or catalytic efficiency - the kcat is reduced over 100-fold, while the KM
values for each substrate are increased only two-fold. It appears therefore that this
residue affects mutase and phosphatase activity by affecting catalysis, rather than by
involvement in the binding of the substrates.
In the higher resolution structure of S. cerevisiae PGAM determined recently
(Rigden et al., 1997), Glu86 is 4.5A from the ND1 atom of Hisl 81. This distance
would be too far to exert influence over the protonation state of this residue.
However, the enzyme was crystallized at pH8.65, and His 181 is very unlikely to be
protonated at this high pH. At the pH optimum of 7.0, the pH at which mutase
activity is assayed, the residue may be protonated, and this may induce the glutamate
to move closer. The position of key active site residues in the 2.3A structure is shown
in figure 7.4.
The synthase activity aapears to be much less affected by the replacement of
the glutamate than the mutase or phosphatase activities (although as described
previously, the low levels of phosphatase and synthase activities does present
difficulties in accurate analysis of changes). This is also consistent with the role
suggested for the residue in phospho transfer. As described in Section 7.1, the first
step of both the mutase and phosphatase activities is the binding of 2,3-BPGA to the
active site, and the transfer of a phospho group to His8. Efficient phospho transfer
requires a proton to be donated, probably from Hisl81, which would therefore need
to be in the protonated state in the unbound enzyme. The first step in the synthase
reaction, on the other hand, involves the binding of 1,3-BPGA, and the transfer of an
acyl phosphate. This does not require the donation of a proton, and is therefore not
dependent on the protonation state of Hisl81. It is likely therefore that the
replacement of a residue which affects the protonation state of Hisl 81 would have a
greater effect on the mutase and phosphatase activties than the synthase activity, and
this is seen. The residue is conserved in the bisphosphoglycerate mutases (see figure
1.4), as would be expected in view of their significant levels of mutase and
phosphatase activities. However, it is not conserved in the third member of the
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Glu 86 Glu 86
Arg 59
Figure 7.4
Stereo diagram of the active site of S. cerevisiae PGAM (from the recent high
resolution structure. Rigden el al., 1997) showing residues thought to be involved in
the reaction mechanism.
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histidine phosphatase family previously described - the acid phosphatases. Only
three out of the five known acid phosphatases have the corresponding residue
conserved. However, recent studies on this enzyme suggest a mechanism that differs
from that of the phosphoglycerate mutases and F-2,6BPase. It is suggested by
Lindqvist et al. (1994) that the proton for phospho transfer is donated not by the
second active site histidine but by an aspartic acid, based both on the proximity and
orientation of the residues and the low pH optimum of the acid phosphatases. The
histidine is implicated in phosphate binding.
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Abstract Electrospray mass spectrometry has been used to
study the formation and hydrolysis of the phopshorvlated forms
of two phosphoglycerate mutases. The half-life of the enzyme
from Saccharomyces cerevisiae was 35 min at 20°C in 10 mM
ammonium bicarbonate, pH 8.0. Addition of 1 mlVl 2-phosphogly-
collate reduced this value by at least 100-fold. The
phosphorylated form of the enzyme from Schizosaccharomyces
pomhe was much less stable with a half-life of less than 1 min.
The results are discussed in terms of the kinetic properties of the
enzymes. Mass spectrometry would appear to be a powerful
method to study the formation and breakdown of phosphorylated
proteins, processes which are of widespread significance in regu¬
latory mechanisms.
Key words: Electrospray mass spectrometry;
Protein phosphorylation; Phosphoglycerate mutase
1. Introduction
The advent of electrospray mass spectrometry with its ability
to measure molecular masses with a precision of ±0.01% has
made it much easier to detect and characterise both post-trans-
lational and chemical modifications of proteins [1 -3]. The in¬
troduction of the phospho group (-OPOf~) in place of-H would
lead to a mass increase of 78 units and thus be readily detecta¬
ble. This approach has been used, for instance, in the delinea¬
tion of the sites of phosphorylation in glycogen synthase [4]
after separation of the modified peptides. However, examina¬
tion of an intact phosphorylated protein by mass spectrometry
does not appear to have been widely studied. In this paper we
describe the use of electrospray mass spectrometry to monitor
the formation of the phosphorylated forms of two phospho¬
glycerate mutases (PGAMs) and to examine the stability of
these phosphorylated enzymes towards hydrolysis.
The catalytic cycle of phosphoglycerate mutase is thought to
proceed via an enzyme-substitution pathway involving the en¬
zyme phosphorylated on a histidine side chain (His-8 in the case
of S. cerevisiae PGAM) [5], The phosphorylated PGAM is
slightly unstable towards hydroysis leading to a low level of
phosphatase activity (approx. 0.002% that of the mutase activ¬
*Corresponding author. Fax: (44) (1786) 464 994.
E-mail: ncpl@stirling.ac.uk
Abbreviations: PGAM, phosphoglycerate mutase; BPG, 2,3-bisphos-
phoglycerate.
ity in the case of the S. cerevisiae enzyme). It has been suggested
[5] that the flexible C-terminal segment (14 amino acids) of this
enzyme may be important in preventing access of water to the
active site and thus maintain a high level ofmutase to phosphat¬
ase activity. Recently the monomeric PGAM from the fission
yeast Schizosaccharomyces pombe has been shown to lack this
flexible C-terminal tail sequence [6]. The kinetic properties of
the S. pombe enzyme have not yet been explored in detail.
2. Experimental
PGAM from an overexpressing strain of 5. cerevisiae was isolated
as described previously [7], with the addition of a final FPLC Superose-
12 gel-filtration step. The concentration of the enzyme was determined
spectrophotometrically assuming a value of 1.45 for the A2m of a
1 mg/ml solution [8],
PGAM from 5. pombe was produced using the PGK-based vector
pMA91 [9] for the high level expression of recombinant GPM'1' in a
transformed null mutant strain of S. cerevisiae (S150-gpm ::HIS3) [7],
The overexpressed S. pombe PGAM was purified in a similar manner
to overexpressed S. cerevisiae PGAM [7]; routinely 10-15 mg of enzyme
of at least 95% purity on SDS-PAGE [10] could be obtained per litre
of cells. Full details of the expression system and enzyme purification
will be published elsewhere (Nairn, Fothergill-Gilmore and Price, in
preparation).
The concentrations of the S. pombe enzyme were determined by a
Coomassie blue binding method [11] using bovine serum albumin as a
standard, or spectrophotometrically using a value for the A280 (1.40 for
a 1 mg/ml solution) calculated from the aromatic amino acid content
of the enzyme [6,12]; the values agreed to within 5%.
The assays of mutase, phosphatase and synthase activities were per¬
formed as described previously [7],
The phosphorylated forms of the PGAMs from S. cerevisiae and
S. pombe were prepared by mixing the enzymes with 2,3-bisphospho-
glycerate (BPG) in 10 mM Tris/HCl, pH 8.0, followed by rapid gel-
filtration on NAP 5 columns (Pharmacia) equilibrated with 10 mM
ammonium bicarbonate, pH 8.0, to remove free mono- and bis-
phosphoglycerates. This procedure allowed samples to be studied by
mass spectrometry within 3 min of the mixing.
Mass spectrometry was performed on a VG Platform quadrupole
mass spectrometer (2-3000 amu range) fitted with a pneumatically
assisted electrospray (ionspray) source and controlled via the VG Mass-
Lynx software (VG Biotech. Ltd, Altrincham, Cheshire, UK). Carrier
solvent (1:1 (v:v) acetonitrile/water) infusion was controlled at 10
/rl/min using a Harvard syringe pump (Harvard Apparatus, South
Natic, MA, USA). Capillary voltages were between 2.8 and 3.2 kV,
extraction cone voltages 20-30 V, and the focussing cone voltage offset
by +10 V. The source temperature was set at 65°C, the nebulising gas
flow at 10 1/h, and the drying gas flow at 250 1/h. Lens stack voltages
were adjusted to give maximum ion currents. The Mr range 700-1500,
which contained >95% of the signal intensity for both unmodified and
phosphorylated forms of PGAM, was scanned with a sweep time of 5 s.
The instrument was calibrated over this M, range immediately before
use with horse heart myoglobin (Sigma). Samples for analysis were
0014-5793/95/S9.50 © 1995 Federation of European Biochemical Societies. All rights reserved.
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diluted with an equal volume of4% (v: v) formic acid in acetonitrile and
10-20 [r 1 aliquots injected directly into the carrier stream. The MaxEnt
deconvolution procedure [13] was applied for quantitative analysis of
the raw data using 1.0 Da peak width and 1 Da/channel resolution.
3. Results and discussion
3.1. S. cerevisiae PGAM
The specific activities of the S. cerevisiae enzyme in the mu-
tase and the phosphatase assays (970 and 0.020 /rmol/min/mg,
respectively) and the effect of 1 mM substrate analogue 2-
phosphoglycollate on the latter activity (18-fold stimulation)
were very similar to those described previously [7].
The mass spectrum of the S. cerevisiae enzyme shows a single
peak of Mr 27478.9 ± 1.0 consistent with the subunit Mr
(27,477) calculated from the cDNA-derived sequence of the
enzyme [14]. After addition of 0.8 molar equivalents (expressed
per active site) of BPG, followed by rapid gel-filtration, the
mass spectrum clearly shows the formation of the
(mono)phosphorylated enzyme, with a mass increase of 79 amu
(Fig. la). Under these conditions, 60% of the total enzyme was
present in the phosphorylated form. There was little or no
(<0.05 molar equivalents per active site) BPG or mono-
phosphoglycerates either free or enzyme bound after the gel-
filtration. By increasing the molar ratio of BPG to 10-fold,
more than 95% of the enzyme could be isolated in the
phosphorylated form (data not shown). When the enzyme
which had been prepared by reaction with the sub-stoichiomet-
ric amount of BPG and then gel-filtered was subsequently incu¬
bated at 20°C, there was a slow loss of the phospho group from
the enzyme. Fig. lb shows the mass spectrum of the sample
taken after 18.5 min incubation. The data from three independ¬
ent experiments expressed as a semi-logarithmic plot are shown
in Fig. lc; in each case the proportion of the enzyme in the
phosphorylated form is expressed relative to the initial propor¬
tion as 100%. From the semi-logarithmic plot the rate constant
for the hydrolysis of the phosphorylated enzyme is 0.02 min"',
corresponding to a half-life of approximately 35 min. This di¬
rect estimate half-life of the phosphorylated form of S. cerevis¬
iae PGAM is rather longer than the value (1-2 min) quoted by
Britton et al. [15] on the basis of unpublished work. It is,
however, clear from preliminary work that the measured phos¬
phatase activity is markedly influenced by factors such as ionic
strength and the presence of phosphorylated substrates and
analogues, and this may well account for at least some of the
observed differences in stability of the phosphorylated enzyme,
i.e. the phosphorylated enzyme would appear to be much less
stable when the enzyme is turning over.
When the mass spectrometry experiment was repeated with
1 mM 2-phosphoglycollate added to the phosphorylated en¬
zyme immediately after gel-filtration, it was found that within
1 min, less than 5% of the enzyme remained in the
phosphorylated form (data not shown). This result indicates
that in the presence of 2-phosphoglycollate the half-life of the
phosphorylated enzyme is less than 20 s (i.e. the rate of the
dephosphorylation reaction is accelerated at least 100-fold in
the presence of this substrate analogue; a somewhat greater
effect than the 18-fold stimulation of phosphatase activity).
In the presence of acetonitrile (50% (v:v)), the
phosphorylated enzyme showed no detectable breakdown after
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Fig. 1. Formation and hydrolysis of the phosphorylated form of
■S. cerevisiae PGAM monitored by mass spectrometry. The spectra over
the Mr range shown (27,420-27,680) were obtained by applying the
MaxEnt deconvolution procedure to the raw data. In each case the size
of the major peak is set as 100%. The peaks labelled E and E-P represent
the dephosphorylated and phosphorylated forms of the enzyme, respec¬
tively. (a) Mass spectrum of the sample immediately after gel-filtration,
(b) Mass spectrum recorded after a further 18.5 min incubation, (c)
Semi-logarithmic plot to show the conversion of the phosphorylated
form to the dephosphorylated form of the enzyme. Data from three
independent experiments are plotted; in each case the initial proportion
of phosphoenzyme (immediately after gel-filtration) is scaled to 100%.
of acetonitrile leads to a considerable loss of secondary struc¬
ture (as shown by far UV CD measurements), it can be con¬
cluded that the denatured phosphorylated enzyme is considera¬
bly more stable towards hydrolysis than is the native
phosphorylated enzyme. This conclusion would be consistent
with earlier work in which negligible breakdown had been
shown to occur over 120 min in the presence of 1.5% (w/v) SDS
[16].
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3.2. S. pombe PGAM
In the mutase assays, the specific activity of S. pombe PGAM
(215 jtmol/min/mg) is about 20% of that of the S. cerevisiae
enzyme, whereas in the phosphatase assay it is some 2.5-fold
higher (0.06 /tmol/min/mg). Thus the ratio of the phosphatase/
mutase assays is 12-fold higher for the S. pombe enzyme. The
degree of stimulation of the phosphatase activity by 2-
phosphoglycollate is considerably lower in the case of the
S. pombe enzyme (4.2-fold).
The mass spectrum of S. pombe PGAM shows a peak with
an Mr of 23679.4 ± 1.5, corresponding to that calculated from
the published sequence [6], assuming that the initiating Met has
been removed and the N-terminal threonine acetylated. On
addition of 0.8 molar equivalents of BPG followed by gel-
filtration (a process lasting 3 min), less than 5% of the enzyme
was present in the phosphorylated form (data not shown). This
was not due to an inability to form the phosphorylated enzyme
since the mixture prior to gel-filtration showed that 60% of the
enzyme was present in the phosphorylated form. From these
results it could be concluded that the half-life of the
phosphorylated form of 5. pombe PGAM was less than 1 min
(at least 35-fold shorter than that of the S. cerevisiae enzyme).
This greater instability of the phosphorylated form of the
S. pombe enzyme is in qualitative agreement with the higher
ratio of phosphatase to mutase activities for this enzyme.
In conclusion, mass spectrometry should prove to be a very
useful technique for monitoring the phosphorylation and
dephosphorylation of a number of enzymes and proteins, a
process which has been recognised to be a key regulatory mech¬
anism for a large number of crucial biological processes [17].
The mass spectrometric technique avoids the necessity of using
radioactive isotopes. Further refinements would include in¬
creasing the time resolution, allowing the rates of faster proc¬
esses to be monitored accurately.
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